id	sid	tid	token	lemma	pos
aijmsr-547	1	1	copyright	copyright	NOUN
aijmsr-547	1	2	©	©	PROPN
aijmsr-547	1	3	cc	cc	PROPN
aijmsr-547	1	4	-	-	PUNCT
aijmsr-547	1	5	by	by	ADP
aijmsr-547	1	6	-	-	PUNCT
aijmsr-547	1	7	nc	nc	PROPN
aijmsr-547	1	8	2020	2020	NUM
aijmsr-547	1	9	,	,	PUNCT
aijmsr-547	1	10	cribfb	cribfb	VERB
aijmsr-547	1	11	|	|	ADV
aijmsr-547	1	12	aijmsr	aijmsr	VERB
aijmsr-547	1	13	american	american	PROPN
aijmsr-547	1	14	international	international	PROPN
aijmsr-547	1	15	journal	journal	PROPN
aijmsr-547	1	16	of	of	ADP
aijmsr-547	1	17	multidisciplinary	multidisciplinary	ADJ
aijmsr-547	1	18	scientific	scientific	ADJ
aijmsr-547	1	19	research	research	NOUN
aijmsr-547	1	20	;	;	PUNCT
aijmsr-547	1	21	vol	vol	NOUN
aijmsr-547	1	22	.	.	PROPN
aijmsr-547	1	23	6	6	NUM
aijmsr-547	1	24	,	,	PUNCT
aijmsr-547	1	25	no	no	INTJ
aijmsr-547	1	26	.	.	NOUN
aijmsr-547	1	27	1	1	NUM
aijmsr-547	1	28	;	;	PUNCT
aijmsr-547	1	29	2020	2020	NUM
aijmsr-547	1	30	issn	issn	VERB
aijmsr-547	1	31	2638	2638	NUM
aijmsr-547	1	32	-	-	SYM
aijmsr-547	1	33	1249	1249	NUM
aijmsr-547	1	34	e	e	NOUN
aijmsr-547	1	35	-	-	PROPN
aijmsr-547	1	36	issn	issn	PROPN
aijmsr-547	1	37	2638	2638	NUM
aijmsr-547	1	38	-	-	SYM
aijmsr-547	1	39	1273	1273	NUM
aijmsr-547	1	40	published	publish	VERB
aijmsr-547	1	41	by	by	ADP
aijmsr-547	1	42	centre	centre	NOUN
aijmsr-547	1	43	for	for	ADP
aijmsr-547	1	44	research	research	NOUN
aijmsr-547	1	45	on	on	ADP
aijmsr-547	1	46	islamic	islamic	ADJ
aijmsr-547	1	47	banking	banking	PROPN
aijmsr-547	1	48	&	&	CCONJ
aijmsr-547	1	49	finance	finance	PROPN
aijmsr-547	1	50	and	and	CCONJ
aijmsr-547	1	51	business	business	NOUN
aijmsr-547	1	52	,	,	PUNCT
aijmsr-547	1	53	usa	usa	PROPN
aijmsr-547	1	54	1	1	NUM
aijmsr-547	1	55	epidemiological	epidemiological	ADJ
aijmsr-547	1	56	and	and	CCONJ
aijmsr-547	1	57	morphological	morphological	ADJ
aijmsr-547	1	58	characteristics	characteristic	NOUN
aijmsr-547	1	59	of	of	ADP
aijmsr-547	1	60	urothelial	urothelial	ADJ
aijmsr-547	1	61	bladder	bladder	NOUN
aijmsr-547	1	62	cancer	cancer	NOUN
aijmsr-547	1	63	in	in	ADP
aijmsr-547	1	64	a	a	DET
aijmsr-547	1	65	bulgarian	bulgarian	NOUN
aijmsr-547	1	66	and	and	CCONJ
aijmsr-547	1	67	a	a	DET
aijmsr-547	1	68	french	french	ADJ
aijmsr-547	1	69	sample	sample	NOUN
aijmsr-547	1	70	of	of	ADP
aijmsr-547	1	71	patients	patient	NOUN
aijmsr-547	1	72	milena	milena	VERB
aijmsr-547	1	73	gulinac	gulinac	PROPN
aijmsr-547	1	74	medical	medical	PROPN
aijmsr-547	1	75	faculty	faculty	PROPN
aijmsr-547	1	76	department	department	PROPN
aijmsr-547	1	77	of	of	ADP
aijmsr-547	1	78	general	general	ADJ
aijmsr-547	1	79	and	and	CCONJ
aijmsr-547	1	80	clinical	clinical	ADJ
aijmsr-547	2	1	pathology	pathology	PROPN
aijmsr-547	2	2	medical	medical	PROPN
aijmsr-547	2	3	university	university	NOUN
aijmsr-547	2	4	-	-	PUNCT
aijmsr-547	2	5	plovdiv	plovdiv	NOUN
aijmsr-547	2	6	,	,	PUNCT
aijmsr-547	2	7	bulgaria	bulgaria	PROPN
aijmsr-547	2	8	e	e	NOUN
aijmsr-547	2	9	-	-	NOUN
aijmsr-547	2	10	mail	mail	NOUN
aijmsr-547	2	11	:	:	PUNCT
aijmsr-547	2	12	mgulinac@hotmail.com	mgulinac@hotmail.com	PROPN
aijmsr-547	2	13	dorian	dorian	PROPN
aijmsr-547	2	14	dikov	dikov	PROPN
aijmsr-547	2	15	grand	grand	PROPN
aijmsr-547	2	16	hospital	hospital	PROPN
aijmsr-547	2	17	de	de	ADP
aijmsr-547	2	18	l’este	l’este	NOUN
aijmsr-547	2	19	francilien	francilien	NOUN
aijmsr-547	2	20	,	,	PUNCT
aijmsr-547	2	21	jossigny	jossigny	PROPN
aijmsr-547	2	22	,	,	PUNCT
aijmsr-547	2	23	france	france	PROPN
aijmsr-547	2	24	medical	medical	ADJ
aijmsr-547	2	25	faculty	faculty	NOUN
aijmsr-547	2	26	,	,	PUNCT
aijmsr-547	2	27	department	department	NOUN
aijmsr-547	2	28	of	of	ADP
aijmsr-547	2	29	general	general	ADJ
aijmsr-547	2	30	and	and	CCONJ
aijmsr-547	2	31	clinical	clinical	ADJ
aijmsr-547	2	32	pathology	pathology	PROPN
aijmsr-547	2	33	medical	medical	PROPN
aijmsr-547	2	34	university	university	NOUN
aijmsr-547	2	35	-	-	PUNCT
aijmsr-547	2	36	plovdiv	plovdiv	NOUN
aijmsr-547	2	37	,	,	PUNCT
aijmsr-547	2	38	bulgaria	bulgaria	PROPN
aijmsr-547	2	39	ts	ts	PROPN
aijmsr-547	2	40	.	.	PUNCT
aijmsr-547	3	1	velikova	velikova	ADP
aijmsr-547	3	2	medical	medical	PROPN
aijmsr-547	3	3	faculty	faculty	PROPN
aijmsr-547	3	4	department	department	PROPN
aijmsr-547	3	5	of	of	ADP
aijmsr-547	3	6	clinical	clinical	ADJ
aijmsr-547	3	7	immunology	immunology	NOUN
aijmsr-547	3	8	university	university	NOUN
aijmsr-547	3	9	hospital	hospital	NOUN
aijmsr-547	3	10	lozenetz	lozenetz	PROPN
aijmsr-547	3	11	-	-	PUNCT
aijmsr-547	3	12	sofia	sofia	NOUN
aijmsr-547	3	13	,	,	PUNCT
aijmsr-547	3	14	bulgaria	bulgaria	PROPN
aijmsr-547	3	15	abstract	abstract	ADJ
aijmsr-547	3	16	bladder	bladder	NOUN
aijmsr-547	3	17	carcinoma	carcinoma	NOUN
aijmsr-547	3	18	(	(	PUNCT
aijmsr-547	3	19	bc	bc	PROPN
aijmsr-547	3	20	)	)	PUNCT
aijmsr-547	3	21	is	be	AUX
aijmsr-547	3	22	one	one	NUM
aijmsr-547	3	23	of	of	ADP
aijmsr-547	3	24	the	the	DET
aijmsr-547	3	25	most	most	ADV
aijmsr-547	3	26	common	common	ADJ
aijmsr-547	3	27	malignancies	malignancy	NOUN
aijmsr-547	3	28	of	of	ADP
aijmsr-547	3	29	the	the	DET
aijmsr-547	3	30	urinary	urinary	ADJ
aijmsr-547	3	31	system	system	NOUN
aijmsr-547	3	32	in	in	ADP
aijmsr-547	3	33	developed	develop	VERB
aijmsr-547	3	34	countries	country	NOUN
aijmsr-547	3	35	,	,	PUNCT
aijmsr-547	3	36	and	and	CCONJ
aijmsr-547	3	37	it	it	PRON
aijmsr-547	3	38	is	be	AUX
aijmsr-547	3	39	also	also	ADV
aijmsr-547	3	40	characterized	characterize	VERB
aijmsr-547	3	41	by	by	ADP
aijmsr-547	3	42	a	a	DET
aijmsr-547	3	43	high	high	ADJ
aijmsr-547	3	44	number	number	NOUN
aijmsr-547	3	45	of	of	ADP
aijmsr-547	3	46	recurrences	recurrence	NOUN
aijmsr-547	3	47	and	and	CCONJ
aijmsr-547	3	48	progression	progression	NOUN
aijmsr-547	3	49	rates	rate	NOUN
aijmsr-547	3	50	despite	despite	SCONJ
aijmsr-547	3	51	multimodal	multimodal	NOUN
aijmsr-547	3	52	treatment	treatment	NOUN
aijmsr-547	3	53	.	.	PUNCT
aijmsr-547	4	1	bc	bc	PROPN
aijmsr-547	4	2	is	be	AUX
aijmsr-547	4	3	a	a	DET
aijmsr-547	4	4	biological	biological	ADJ
aijmsr-547	4	5	and	and	CCONJ
aijmsr-547	4	6	clinically	clinically	ADV
aijmsr-547	4	7	heterogeneous	heterogeneous	ADJ
aijmsr-547	4	8	tumor	tumor	NOUN
aijmsr-547	4	9	with	with	ADP
aijmsr-547	4	10	a	a	DET
aijmsr-547	4	11	great	great	ADJ
aijmsr-547	4	12	propensity	propensity	NOUN
aijmsr-547	4	13	of	of	ADP
aijmsr-547	4	14	divergent	divergent	ADJ
aijmsr-547	4	15	differentiation	differentiation	NOUN
aijmsr-547	4	16	.	.	PUNCT
aijmsr-547	5	1	around	around	ADP
aijmsr-547	5	2	the	the	DET
aijmsr-547	5	3	world	world	NOUN
aijmsr-547	5	4	,	,	PUNCT
aijmsr-547	5	5	bladder	bladder	NOUN
aijmsr-547	5	6	cancer	cancer	NOUN
aijmsr-547	5	7	is	be	AUX
aijmsr-547	5	8	responsible	responsible	ADJ
aijmsr-547	5	9	for	for	ADP
aijmsr-547	5	10	549.000	549.000	NUM
aijmsr-547	5	11	new	new	ADJ
aijmsr-547	5	12	cases	case	NOUN
aijmsr-547	5	13	и	и	NOUN
aijmsr-547	5	14	200.000	200.000	NUM
aijmsr-547	5	15	deaths	death	NOUN
aijmsr-547	5	16	each	each	DET
aijmsr-547	5	17	year	year	NOUN
aijmsr-547	5	18	.	.	PUNCT
aijmsr-547	6	1	in	in	ADP
aijmsr-547	6	2	bulgaria	bulgaria	PROPN
aijmsr-547	6	3	,	,	PUNCT
aijmsr-547	6	4	bladder	bladder	NOUN
aijmsr-547	6	5	carcinoma	carcinoma	NOUN
aijmsr-547	6	6	is	be	AUX
aijmsr-547	6	7	the	the	DET
aijmsr-547	6	8	18th	18th	ADJ
aijmsr-547	6	9	most	most	ADV
aijmsr-547	6	10	common	common	ADJ
aijmsr-547	6	11	neoplasia	neoplasia	NOUN
aijmsr-547	6	12	.	.	PUNCT
aijmsr-547	7	1	our	our	PRON
aijmsr-547	7	2	results	result	NOUN
aijmsr-547	7	3	on	on	ADP
aijmsr-547	7	4	105	105	NUM
aijmsr-547	7	5	proven	proven	ADJ
aijmsr-547	7	6	bladder	bladder	NOUN
aijmsr-547	7	7	carcinoma	carcinoma	NOUN
aijmsr-547	7	8	cases	case	NOUN
aijmsr-547	7	9	confirmed	confirm	VERB
aijmsr-547	7	10	that	that	SCONJ
aijmsr-547	7	11	this	this	DET
aijmsr-547	7	12	tumor	tumor	NOUN
aijmsr-547	7	13	arises	arise	VERB
aijmsr-547	7	14	at	at	ADP
aijmsr-547	7	15	70	70	NUM
aijmsr-547	7	16	years	year	NOUN
aijmsr-547	7	17	at	at	ADP
aijmsr-547	7	18	average	average	ADJ
aijmsr-547	7	19	(	(	PUNCT
aijmsr-547	7	20	60	60	NUM
aijmsr-547	7	21	-	-	SYM
aijmsr-547	7	22	90	90	NUM
aijmsr-547	7	23	years	year	NOUN
aijmsr-547	7	24	)	)	PUNCT
aijmsr-547	7	25	,	,	PUNCT
aijmsr-547	7	26	it	it	PRON
aijmsr-547	7	27	affects	affect	VERB
aijmsr-547	7	28	men	man	NOUN
aijmsr-547	7	29	predominantly	predominantly	ADV
aijmsr-547	7	30	and	and	CCONJ
aijmsr-547	7	31	there	there	PRON
aijmsr-547	7	32	was	be	VERB
aijmsr-547	7	33	no	no	DET
aijmsr-547	7	34	difference	difference	NOUN
aijmsr-547	7	35	regarding	regard	VERB
aijmsr-547	7	36	the	the	DET
aijmsr-547	7	37	nationality	nationality	NOUN
aijmsr-547	7	38	of	of	ADP
aijmsr-547	7	39	patients	patient	NOUN
aijmsr-547	7	40	.	.	PUNCT
aijmsr-547	8	1	in	in	ADP
aijmsr-547	8	2	conclusion	conclusion	NOUN
aijmsr-547	8	3	,	,	PUNCT
aijmsr-547	8	4	it	it	PRON
aijmsr-547	8	5	remains	remain	VERB
aijmsr-547	8	6	a	a	DET
aijmsr-547	8	7	diagnostic	diagnostic	ADJ
aijmsr-547	8	8	challenge	challenge	NOUN
aijmsr-547	8	9	.	.	PUNCT
aijmsr-547	9	1	keywords	keyword	NOUN
aijmsr-547	9	2	:	:	PUNCT
aijmsr-547	9	3	bladder	bladder	NOUN
aijmsr-547	9	4	cancer	cancer	NOUN
aijmsr-547	9	5	,	,	PUNCT
aijmsr-547	9	6	urothelial	urothelial	ADJ
aijmsr-547	9	7	carcinoma	carcinoma	NOUN
aijmsr-547	9	8	,	,	PUNCT
aijmsr-547	9	9	urinary	urinary	ADJ
aijmsr-547	9	10	tract	tract	NOUN
aijmsr-547	9	11	.	.	PUNCT
aijmsr-547	10	1	1	1	X
aijmsr-547	10	2	.	.	X
aijmsr-547	10	3	introduction	introduction	NOUN
aijmsr-547	10	4	urothelial	urothelial	ADJ
aijmsr-547	10	5	bladder	bladder	NOUN
aijmsr-547	10	6	cancer	cancer	NOUN
aijmsr-547	10	7	is	be	AUX
aijmsr-547	10	8	a	a	DET
aijmsr-547	10	9	common	common	ADJ
aijmsr-547	10	10	disease	disease	NOUN
aijmsr-547	10	11	that	that	PRON
aijmsr-547	10	12	takes	take	VERB
aijmsr-547	10	13	the	the	DET
aijmsr-547	10	14	9	9	NUM
aijmsr-547	10	15	th	th	NOUN
aijmsr-547	10	16	rank	rank	NOUN
aijmsr-547	10	17	in	in	ADP
aijmsr-547	10	18	worldwide	worldwide	ADJ
aijmsr-547	10	19	cancer	cancer	NOUN
aijmsr-547	10	20	incidence	incidence	NOUN
aijmsr-547	10	21	(	(	PUNCT
aijmsr-547	10	22	ploeg	ploeg	PROPN
aijmsr-547	10	23	et	et	PROPN
aijmsr-547	10	24	al	al	PROPN
aijmsr-547	10	25	.	.	PROPN
aijmsr-547	10	26	,	,	PUNCT
aijmsr-547	10	27	2009	2009	NUM
aijmsr-547	10	28	)	)	PUNCT
aijmsr-547	10	29	.	.	PUNCT
aijmsr-547	11	1	the	the	DET
aijmsr-547	11	2	incidence	incidence	NOUN
aijmsr-547	11	3	of	of	ADP
aijmsr-547	11	4	bladder	bladder	NOUN
aijmsr-547	11	5	cancer	cancer	NOUN
aijmsr-547	11	6	is	be	AUX
aijmsr-547	11	7	three	three	NUM
aijmsr-547	11	8	times	time	NOUN
aijmsr-547	11	9	greater	great	ADJ
aijmsr-547	11	10	in	in	ADP
aijmsr-547	11	11	males	male	NOUN
aijmsr-547	11	12	than	than	ADP
aijmsr-547	11	13	in	in	ADP
aijmsr-547	11	14	females	female	NOUN
aijmsr-547	11	15	(	(	PUNCT
aijmsr-547	11	16	hartge	hartge	PROPN
aijmsr-547	11	17	et	et	PROPN
aijmsr-547	11	18	al	al	PROPN
aijmsr-547	11	19	.	.	PROPN
aijmsr-547	11	20	,	,	PUNCT
aijmsr-547	11	21	1990	1990	NUM
aijmsr-547	11	22	)	)	PUNCT
aijmsr-547	11	23	.	.	PUNCT
aijmsr-547	12	1	these	these	DET
aijmsr-547	12	2	differences	difference	NOUN
aijmsr-547	12	3	in	in	ADP
aijmsr-547	12	4	gender	gender	NOUN
aijmsr-547	12	5	prevalence	prevalence	NOUN
aijmsr-547	12	6	explained	explain	VERB
aijmsr-547	12	7	largely	largely	ADV
aijmsr-547	12	8	by	by	ADP
aijmsr-547	12	9	differences	difference	NOUN
aijmsr-547	12	10	in	in	ADP
aijmsr-547	12	11	exposure	exposure	NOUN
aijmsr-547	12	12	to	to	ADP
aijmsr-547	12	13	certain	certain	ADJ
aijmsr-547	12	14	risk	risk	NOUN
aijmsr-547	12	15	factors	factor	NOUN
aijmsr-547	12	16	.	.	PUNCT
aijmsr-547	13	1	in	in	ADP
aijmsr-547	13	2	the	the	DET
aijmsr-547	13	3	developed	develop	VERB
aijmsr-547	13	4	country	country	NOUN
aijmsr-547	13	5	,	,	PUNCT
aijmsr-547	13	6	the	the	DET
aijmsr-547	13	7	major	major	ADJ
aijmsr-547	13	8	risk	risk	NOUN
aijmsr-547	13	9	factor	factor	NOUN
aijmsr-547	13	10	is	be	AUX
aijmsr-547	13	11	smoking	smoke	VERB
aijmsr-547	13	12	(	(	PUNCT
aijmsr-547	13	13	aydin	aydin	NOUN
aijmsr-547	13	14	et	et	PROPN
aijmsr-547	13	15	al	al	PROPN
aijmsr-547	13	16	.	.	PROPN
aijmsr-547	13	17	,	,	PUNCT
aijmsr-547	13	18	2017	2017	NUM
aijmsr-547	13	19	;	;	PUNCT
aijmsr-547	13	20	battista	battista	PROPN
aijmsr-547	13	21	di	di	PROPN
aijmsr-547	13	22	pierro	pierro	PROPN
aijmsr-547	13	23	et	et	PROPN
aijmsr-547	13	24	al	al	PROPN
aijmsr-547	13	25	.	.	PROPN
aijmsr-547	13	26	,	,	PUNCT
aijmsr-547	13	27	2012	2012	NUM
aijmsr-547	13	28	;	;	PUNCT
aijmsr-547	13	29	gilbert	gilbert	PROPN
aijmsr-547	13	30	et	et	PROPN
aijmsr-547	13	31	al	al	PROPN
aijmsr-547	13	32	.	.	PROPN
aijmsr-547	13	33	,	,	PUNCT
aijmsr-547	13	34	2004	2004	NUM
aijmsr-547	13	35	)	)	PUNCT
aijmsr-547	13	36	.	.	PUNCT
aijmsr-547	14	1	in	in	ADP
aijmsr-547	14	2	western	western	ADJ
aijmsr-547	14	3	countries	country	NOUN
aijmsr-547	14	4	,	,	PUNCT
aijmsr-547	14	5	smoking	smoking	NOUN
aijmsr-547	14	6	is	be	AUX
aijmsr-547	14	7	responsible	responsible	ADJ
aijmsr-547	14	8	for	for	ADP
aijmsr-547	14	9	around	around	ADV
aijmsr-547	14	10	50	50	NUM
aijmsr-547	14	11	%	%	NOUN
aijmsr-547	14	12	of	of	ADP
aijmsr-547	14	13	urothelial	urothelial	ADJ
aijmsr-547	14	14	bladder	bladder	NOUN
aijmsr-547	14	15	cancer	cancer	NOUN
aijmsr-547	14	16	in	in	ADP
aijmsr-547	14	17	males	male	NOUN
aijmsr-547	14	18	and	and	CCONJ
aijmsr-547	14	19	35	35	NUM
aijmsr-547	14	20	%	%	NOUN
aijmsr-547	14	21	in	in	ADP
aijmsr-547	14	22	females	female	NOUN
aijmsr-547	14	23	(	(	PUNCT
aijmsr-547	14	24	ploeg	ploeg	PROPN
aijmsr-547	14	25	et	et	PROPN
aijmsr-547	14	26	al	al	PROPN
aijmsr-547	14	27	.	.	PROPN
aijmsr-547	14	28	,	,	PUNCT
aijmsr-547	14	29	2009	2009	NUM
aijmsr-547	14	30	)	)	PUNCT
aijmsr-547	14	31	.	.	PUNCT
aijmsr-547	15	1	on	on	ADP
aijmsr-547	15	2	the	the	DET
aijmsr-547	15	3	other	other	ADJ
aijmsr-547	15	4	hand	hand	NOUN
aijmsr-547	15	5	,	,	PUNCT
aijmsr-547	15	6	in	in	ADP
aijmsr-547	15	7	countries	country	NOUN
aijmsr-547	15	8	where	where	SCONJ
aijmsr-547	15	9	the	the	DET
aijmsr-547	15	10	infection	infection	NOUN
aijmsr-547	15	11	caused	cause	VERB
aijmsr-547	15	12	by	by	ADP
aijmsr-547	15	13	schistosoma	schistosoma	ADJ
aijmsr-547	15	14	haematobium	haematobium	NOUN
aijmsr-547	15	15	is	be	AUX
aijmsr-547	15	16	endemic	endemic	ADJ
aijmsr-547	15	17	,	,	PUNCT
aijmsr-547	15	18	like	like	ADP
aijmsr-547	15	19	egypt	egypt	PROPN
aijmsr-547	15	20	,	,	PUNCT
aijmsr-547	15	21	primary	primary	ADJ
aijmsr-547	15	22	squamous	squamous	ADJ
aijmsr-547	15	23	cell	cell	NOUN
aijmsr-547	15	24	carcinoma	carcinoma	NOUN
aijmsr-547	15	25	of	of	ADP
aijmsr-547	15	26	the	the	DET
aijmsr-547	15	27	bladder	bladder	NOUN
aijmsr-547	15	28	is	be	AUX
aijmsr-547	15	29	the	the	DET
aijmsr-547	15	30	dominant	dominant	ADJ
aijmsr-547	15	31	histological	histological	ADJ
aijmsr-547	15	32	type	type	NOUN
aijmsr-547	15	33	.	.	PUNCT
aijmsr-547	16	1	the	the	DET
aijmsr-547	16	2	third	third	ADJ
aijmsr-547	16	3	most	most	ADV
aijmsr-547	16	4	important	important	ADJ
aijmsr-547	16	5	risk	risk	NOUN
aijmsr-547	16	6	factor	factor	NOUN
aijmsr-547	16	7	for	for	ADP
aijmsr-547	16	8	bladder	bladder	NOUN
aijmsr-547	16	9	cancer	cancer	NOUN
aijmsr-547	16	10	development	development	NOUN
aijmsr-547	16	11	is	be	AUX
aijmsr-547	16	12	occupational	occupational	ADJ
aijmsr-547	16	13	exposure	exposure	NOUN
aijmsr-547	16	14	,	,	PUNCT
aijmsr-547	16	15	as	as	ADP
aijmsr-547	16	16	chronic	chronic	ADJ
aijmsr-547	16	17	exposure	exposure	NOUN
aijmsr-547	16	18	to	to	ADP
aijmsr-547	16	19	arsenic	arsenic	VERB
aijmsr-547	16	20	.	.	PUNCT
aijmsr-547	17	1	carcinoma	carcinoma	NOUN
aijmsr-547	17	2	of	of	ADP
aijmsr-547	17	3	the	the	DET
aijmsr-547	17	4	bladder	bladder	NOUN
aijmsr-547	17	5	is	be	AUX
aijmsr-547	17	6	a	a	DET
aijmsr-547	17	7	7th	7th	ADJ
aijmsr-547	17	8	most	most	ADV
aijmsr-547	17	9	common	common	ADJ
aijmsr-547	17	10	malignant	malignant	ADJ
aijmsr-547	17	11	disease	disease	NOUN
aijmsr-547	17	12	in	in	ADP
aijmsr-547	17	13	men	man	NOUN
aijmsr-547	17	14	and	and	CCONJ
aijmsr-547	17	15	17th	17th	NOUN
aijmsr-547	17	16	in	in	ADP
aijmsr-547	17	17	women	woman	NOUN
aijmsr-547	17	18	.	.	PUNCT
aijmsr-547	18	1	the	the	DET
aijmsr-547	18	2	majority	majority	NOUN
aijmsr-547	18	3	of	of	ADP
aijmsr-547	18	4	bladder	bladder	NOUN
aijmsr-547	18	5	cancer	cancer	NOUN
aijmsr-547	18	6	is	be	AUX
aijmsr-547	18	7	composed	compose	VERB
aijmsr-547	18	8	of	of	ADP
aijmsr-547	18	9	urothelial	urothelial	ADJ
aijmsr-547	18	10	carcinoma	carcinoma	NOUN
aijmsr-547	18	11	(	(	PUNCT
aijmsr-547	18	12	90	90	NUM
aijmsr-547	18	13	%	%	NOUN
aijmsr-547	18	14	)	)	PUNCT
aijmsr-547	18	15	,	,	PUNCT
aijmsr-547	18	16	where	where	SCONJ
aijmsr-547	18	17	the	the	DET
aijmsr-547	18	18	remaining	remain	VERB
aijmsr-547	18	19	less	less	ADV
aijmsr-547	18	20	common	common	ADJ
aijmsr-547	18	21	types	type	NOUN
aijmsr-547	18	22	include	include	VERB
aijmsr-547	18	23	primary	primary	ADJ
aijmsr-547	18	24	bladder	bladder	NOUN
aijmsr-547	18	25	’s	’s	PART
aijmsr-547	18	26	adenocarcinoma	adenocarcinoma	NOUN
aijmsr-547	18	27	,	,	PUNCT
aijmsr-547	18	28	squamous	squamous	ADJ
aijmsr-547	18	29	cell	cell	NOUN
aijmsr-547	18	30	carcinoma	carcinoma	NOUN
aijmsr-547	18	31	,	,	PUNCT
aijmsr-547	18	32	and	and	CCONJ
aijmsr-547	18	33	neuroendocrine	neuroendocrine	ADJ
aijmsr-547	18	34	carcinomas	carcinoma	NOUN
aijmsr-547	18	35	(	(	PUNCT
aijmsr-547	18	36	small	small	ADJ
aijmsr-547	18	37	cell	cell	NOUN
aijmsr-547	18	38	carcinoma	carcinoma	NOUN
aijmsr-547	18	39	)	)	PUNCT
aijmsr-547	18	40	(	(	PUNCT
aijmsr-547	18	41	carneiro	carneiro	PROPN
aijmsr-547	18	42	et	et	PROPN
aijmsr-547	18	43	al	al	PROPN
aijmsr-547	18	44	.	.	PROPN
aijmsr-547	18	45	,	,	PUNCT
aijmsr-547	18	46	2015	2015	NUM
aijmsr-547	18	47	)	)	PUNCT
aijmsr-547	18	48	.	.	PUNCT
aijmsr-547	19	1	urothelial	urothelial	ADJ
aijmsr-547	19	2	carcinoma	carcinoma	NOUN
aijmsr-547	19	3	of	of	ADP
aijmsr-547	19	4	the	the	DET
aijmsr-547	19	5	bladder	bladder	NOUN
aijmsr-547	19	6	is	be	AUX
aijmsr-547	19	7	usually	usually	ADV
aijmsr-547	19	8	admixed	admix	VERB
aijmsr-547	19	9	with	with	ADP
aijmsr-547	19	10	other	other	ADJ
aijmsr-547	19	11	morphologically	morphologically	ADV
aijmsr-547	19	12	recognizable	recognizable	ADJ
aijmsr-547	19	13	differentiations	differentiation	NOUN
aijmsr-547	19	14	(	(	PUNCT
aijmsr-547	19	15	beltran	beltran	PROPN
aijmsr-547	19	16	et	et	PROPN
aijmsr-547	19	17	al	al	PROPN
aijmsr-547	19	18	.	.	PROPN
aijmsr-547	19	19	,	,	PUNCT
aijmsr-547	19	20	2017	2017	NUM
aijmsr-547	19	21	)	)	PUNCT
aijmsr-547	19	22	.	.	PUNCT
aijmsr-547	20	1	in	in	ADP
aijmsr-547	20	2	recent	recent	ADJ
aijmsr-547	20	3	years	year	NOUN
aijmsr-547	20	4	,	,	PUNCT
aijmsr-547	20	5	the	the	DET
aijmsr-547	20	6	spectrum	spectrum	NOUN
aijmsr-547	20	7	of	of	ADP
aijmsr-547	20	8	microscopic	microscopic	ADJ
aijmsr-547	20	9	forms	form	NOUN
aijmsr-547	20	10	of	of	ADP
aijmsr-547	20	11	urothelial	urothelial	ADJ
aijmsr-547	20	12	carcinoma	carcinoma	NOUN
aijmsr-547	20	13	has	have	AUX
aijmsr-547	20	14	been	be	AUX
aijmsr-547	20	15	expanded	expand	VERB
aijmsr-547	20	16	to	to	PART
aijmsr-547	20	17	include	include	VERB
aijmsr-547	20	18	several	several	ADJ
aijmsr-547	20	19	histological	histological	ADJ
aijmsr-547	20	20	variants	variant	NOUN
aijmsr-547	20	21	.	.	PUNCT
aijmsr-547	21	1	most	most	ADJ
aijmsr-547	21	2	of	of	ADP
aijmsr-547	21	3	them	they	PRON
aijmsr-547	21	4	are	be	AUX
aijmsr-547	21	5	described	describe	VERB
aijmsr-547	21	6	in	in	ADP
aijmsr-547	21	7	the	the	DET
aijmsr-547	21	8	world	world	PROPN
aijmsr-547	21	9	health	health	NOUN
aijmsr-547	21	10	organization	organization	NOUN
aijmsr-547	21	11	(	(	PUNCT
aijmsr-547	21	12	who2016	who2016	PROPN
aijmsr-547	21	13	)	)	PUNCT
aijmsr-547	21	14	book	book	NOUN
aijmsr-547	21	15	(	(	PUNCT
aijmsr-547	21	16	moch	moch	PROPN
aijmsr-547	21	17	et	et	PROPN
aijmsr-547	21	18	al	al	PROPN
aijmsr-547	21	19	.	.	PROPN
aijmsr-547	21	20	,	,	PUNCT
aijmsr-547	21	21	2016	2016	NUM
aijmsr-547	21	22	)	)	PUNCT
aijmsr-547	21	23	.	.	PUNCT
aijmsr-547	22	1	the	the	DET
aijmsr-547	22	2	recognition	recognition	NOUN
aijmsr-547	22	3	of	of	ADP
aijmsr-547	22	4	histological	histological	ADJ
aijmsr-547	22	5	variants	variant	NOUN
aijmsr-547	22	6	in	in	ADP
aijmsr-547	22	7	urothelial	urothelial	ADJ
aijmsr-547	22	8	neoplasia	neoplasia	NOUN
aijmsr-547	22	9	is	be	AUX
aijmsr-547	22	10	essential	essential	ADJ
aijmsr-547	22	11	for	for	ADP
aijmsr-547	22	12	a	a	DET
aijmsr-547	22	13	pathologist	pathologist	NOUN
aijmsr-547	22	14	and	and	CCONJ
aijmsr-547	22	15	oncologist	oncologist	NOUN
aijmsr-547	22	16	because	because	SCONJ
aijmsr-547	22	17	different	different	ADJ
aijmsr-547	22	18	https://www.ncbi.nlm.nih.gov/pubmed/?term=hartge%20p%5bauthor%5d&cauthor=true&cauthor_uid=2213906	https://www.ncbi.nlm.nih.gov/pubmed/?term=hartge%20p%5bauthor%5d&cauthor=true&cauthor_uid=2213906	X
aijmsr-547	22	19	https://www.ncbi.nlm.nih.gov/pubmed/?term=gilbert%20d%5bauthor%5d&cauthor=true&cauthor_uid=15203798	https://www.ncbi.nlm.nih.gov/pubmed/?term=gilbert%20d%5bauthor%5d&cauthor=true&cauthor_uid=15203798	PROPN
aijmsr-547	22	20	https://www.ncbi.nlm.nih.gov/pubmed/?term=carneiro%20ba%5bauthor%5d&cauthor=true&cauthor_uid=25498841	https://www.ncbi.nlm.nih.gov/pubmed/?term=carneiro%20ba%5bauthor%5d&cauthor=true&cauthor_uid=25498841	PROPN
aijmsr-547	22	21	https://www.ncbi.nlm.nih.gov/pubmed/?term=moch%20h%5bauthor%5d&cauthor=true&cauthor_uid=26935559	https://www.ncbi.nlm.nih.gov/pubmed/?term=moch%20h%5bauthor%5d&cauthor=true&cauthor_uid=26935559	NUM
aijmsr-547	22	22	copyright	copyright	NOUN
aijmsr-547	22	23	©	©	PROPN
aijmsr-547	22	24	cc	cc	PROPN
aijmsr-547	22	25	-	-	PUNCT
aijmsr-547	22	26	by	by	ADP
aijmsr-547	22	27	-	-	PUNCT
aijmsr-547	22	28	nc	nc	PROPN
aijmsr-547	22	29	2020	2020	NUM
aijmsr-547	22	30	,	,	PUNCT
aijmsr-547	22	31	cribfb	cribfb	VERB
aijmsr-547	22	32	|	|	CCONJ
aijmsr-547	22	33	aijmsr	aijmsr	NOUN
aijmsr-547	22	34	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-547	22	35	american	american	PROPN
aijmsr-547	22	36	international	international	PROPN
aijmsr-547	22	37	journal	journal	PROPN
aijmsr-547	22	38	of	of	ADP
aijmsr-547	22	39	multidisciplinary	multidisciplinary	ADJ
aijmsr-547	22	40	scientific	scientific	ADJ
aijmsr-547	22	41	research	research	NOUN
aijmsr-547	22	42	vol	vol	NOUN
aijmsr-547	22	43	.	.	PROPN
aijmsr-547	23	1	6	6	NUM
aijmsr-547	23	2	,	,	PUNCT
aijmsr-547	23	3	no	no	INTJ
aijmsr-547	23	4	.	.	NOUN
aijmsr-547	23	5	1	1	NUM
aijmsr-547	23	6	;	;	PUNCT
aijmsr-547	23	7	2020	2020	NUM
aijmsr-547	23	8	2	2	NUM
aijmsr-547	23	9	histology	histology	NOUN
aijmsr-547	23	10	subtypes	subtype	NOUN
aijmsr-547	23	11	of	of	ADP
aijmsr-547	23	12	urothelial	urothelial	ADJ
aijmsr-547	23	13	cancer	cancer	NOUN
aijmsr-547	23	14	of	of	ADP
aijmsr-547	23	15	the	the	DET
aijmsr-547	23	16	bladder	bladder	NOUN
aijmsr-547	23	17	may	may	AUX
aijmsr-547	23	18	be	be	AUX
aijmsr-547	23	19	associated	associate	VERB
aijmsr-547	23	20	with	with	ADP
aijmsr-547	23	21	different	different	ADJ
aijmsr-547	23	22	clinical	clinical	ADJ
aijmsr-547	23	23	outcomes	outcome	NOUN
aijmsr-547	23	24	and	and	CCONJ
aijmsr-547	23	25	have	have	VERB
aijmsr-547	23	26	a	a	DET
aijmsr-547	23	27	different	different	ADJ
aijmsr-547	23	28	therapeutic	therapeutic	ADJ
aijmsr-547	23	29	approach	approach	NOUN
aijmsr-547	23	30	.	.	PUNCT
aijmsr-547	24	1	2	2	X
aijmsr-547	24	2	.	.	X
aijmsr-547	24	3	materials	material	NOUN
aijmsr-547	24	4	and	and	CCONJ
aijmsr-547	24	5	methods	method	NOUN
aijmsr-547	24	6	we	we	PRON
aijmsr-547	24	7	examined	examine	VERB
aijmsr-547	24	8	105	105	NUM
aijmsr-547	24	9	cases	case	NOUN
aijmsr-547	24	10	of	of	ADP
aijmsr-547	24	11	urothelial	urothelial	ADJ
aijmsr-547	24	12	carcinoma	carcinoma	NOUN
aijmsr-547	24	13	from	from	ADP
aijmsr-547	24	14	tissue	tissue	NOUN
aijmsr-547	24	15	database	database	NOUN
aijmsr-547	24	16	of	of	ADP
aijmsr-547	24	17	university	university	NOUN
aijmsr-547	24	18	hospital	hospital	NOUN
aijmsr-547	24	19	“	"	PUNCT
aijmsr-547	24	20	st	st	PROPN
aijmsr-547	24	21	.	.	PROPN
aijmsr-547	24	22	george	george	PROPN
aijmsr-547	24	23	“	"	PUNCT
aijmsr-547	24	24	plovdiv	plovdiv	PROPN
aijmsr-547	24	25	,	,	PUNCT
aijmsr-547	24	26	bulgaria	bulgaria	PROPN
aijmsr-547	24	27	and	and	CCONJ
aijmsr-547	24	28	grand	grand	ADJ
aijmsr-547	24	29	hospital	hospital	NOUN
aijmsr-547	24	30	de	de	ADP
aijmsr-547	24	31	l’este	l’este	NOUN
aijmsr-547	24	32	francilien	francilien	NOUN
aijmsr-547	24	33	,	,	PUNCT
aijmsr-547	24	34	jossigny	jossigny	PROPN
aijmsr-547	24	35	,	,	PUNCT
aijmsr-547	24	36	france	france	PROPN
aijmsr-547	24	37	,	,	PUNCT
aijmsr-547	24	38	and	and	CCONJ
aijmsr-547	24	39	reviewed	review	VERB
aijmsr-547	24	40	the	the	DET
aijmsr-547	24	41	period	period	NOUN
aijmsr-547	24	42	from	from	ADP
aijmsr-547	24	43	2016	2016	NUM
aijmsr-547	24	44	to	to	ADP
aijmsr-547	24	45	2020	2020	NUM
aijmsr-547	24	46	.	.	PUNCT
aijmsr-547	25	1	all	all	DET
aijmsr-547	25	2	analyzed	analyze	VERB
aijmsr-547	25	3	patients	patient	NOUN
aijmsr-547	25	4	in	in	ADP
aijmsr-547	25	5	this	this	DET
aijmsr-547	25	6	study	study	NOUN
aijmsr-547	25	7	have	have	AUX
aijmsr-547	25	8	been	be	AUX
aijmsr-547	25	9	diagnosed	diagnose	VERB
aijmsr-547	25	10	with	with	ADP
aijmsr-547	25	11	invasive	invasive	ADJ
aijmsr-547	25	12	or	or	CCONJ
aijmsr-547	25	13	non	non	ADJ
aijmsr-547	25	14	-	-	ADJ
aijmsr-547	25	15	invasive	invasive	ADJ
aijmsr-547	25	16	high	high	ADJ
aijmsr-547	25	17	-	-	PUNCT
aijmsr-547	25	18	grade	grade	NOUN
aijmsr-547	25	19	(	(	PUNCT
aijmsr-547	25	20	hg	hg	NOUN
aijmsr-547	25	21	)	)	PUNCT
aijmsr-547	25	22	and	and	CCONJ
aijmsr-547	25	23	low	low	ADJ
aijmsr-547	25	24	-	-	PUNCT
aijmsr-547	25	25	grade	grade	NOUN
aijmsr-547	25	26	(	(	PUNCT
aijmsr-547	25	27	lg	lg	NOUN
aijmsr-547	25	28	)	)	PUNCT
aijmsr-547	25	29	urothelial	urothelial	ADJ
aijmsr-547	25	30	carcinomas	carcinoma	NOUN
aijmsr-547	25	31	of	of	ADP
aijmsr-547	25	32	the	the	DET
aijmsr-547	25	33	bladder	bladder	NOUN
aijmsr-547	25	34	.	.	PUNCT
aijmsr-547	26	1	histological	histological	ADJ
aijmsr-547	26	2	analysis	analysis	NOUN
aijmsr-547	26	3	of	of	ADP
aijmsr-547	26	4	the	the	DET
aijmsr-547	26	5	tissues	tissue	NOUN
aijmsr-547	26	6	was	be	AUX
aijmsr-547	26	7	performed	perform	VERB
aijmsr-547	26	8	using	use	VERB
aijmsr-547	26	9	automatic	automatic	ADJ
aijmsr-547	26	10	tissue	tissue	NOUN
aijmsr-547	26	11	processor	processor	NOUN
aijmsr-547	26	12	„	„	PUNCT
aijmsr-547	26	13	diapath	diapath	X
aijmsr-547	26	14	en	en	X
aijmsr-547	26	15	iso	iso	NOUN
aijmsr-547	26	16	9001:2000	9001:2000	NUM
aijmsr-547	26	17	“	"	PUNCT
aijmsr-547	26	18	and	and	CCONJ
aijmsr-547	26	19	4	4	NUM
aijmsr-547	26	20	-	-	SYM
aijmsr-547	26	21	5	5	NUM
aijmsr-547	26	22	μm	μm	NUM
aijmsr-547	26	23	formalin	formalin	NOUN
aijmsr-547	26	24	-	-	PUNCT
aijmsr-547	26	25	fixed	fix	VERB
aijmsr-547	26	26	paraffin	paraffin	NOUN
aijmsr-547	26	27	-	-	PUNCT
aijmsr-547	26	28	embedded	embed	VERB
aijmsr-547	26	29	tissue	tissue	NOUN
aijmsr-547	26	30	sections	section	NOUN
aijmsr-547	26	31	underwent	undergo	VERB
aijmsr-547	26	32	routine	routine	ADJ
aijmsr-547	26	33	staining	stain	VERB
aijmsr-547	26	34	with	with	ADP
aijmsr-547	26	35	hematoxylin	hematoxylin	NOUN
aijmsr-547	26	36	-	-	PUNCT
aijmsr-547	26	37	eosin	eosin	NOUN
aijmsr-547	26	38	(	(	PUNCT
aijmsr-547	26	39	he	he	PRON
aijmsr-547	26	40	)	)	PUNCT
aijmsr-547	26	41	and	and	CCONJ
aijmsr-547	26	42	hematoxylin	hematoxylin	NOUN
aijmsr-547	26	43	-	-	PUNCT
aijmsr-547	26	44	eosin	eosin	NOUN
aijmsr-547	26	45	-	-	PUNCT
aijmsr-547	26	46	safran	safran	NOUN
aijmsr-547	26	47	(	(	PUNCT
aijmsr-547	26	48	he	he	PRON
aijmsr-547	26	49	s	s	VERB
aijmsr-547	26	50	)	)	PUNCT
aijmsr-547	26	51	to	to	PART
aijmsr-547	26	52	determine	determine	VERB
aijmsr-547	26	53	the	the	DET
aijmsr-547	26	54	presence	presence	NOUN
aijmsr-547	26	55	of	of	ADP
aijmsr-547	26	56	individual	individual	ADJ
aijmsr-547	26	57	histological	histological	ADJ
aijmsr-547	26	58	features	feature	NOUN
aijmsr-547	26	59	.	.	PUNCT
aijmsr-547	27	1	statistical	statistical	ADJ
aijmsr-547	27	2	analysis	analysis	NOUN
aijmsr-547	27	3	was	be	AUX
aijmsr-547	27	4	performed	perform	VERB
aijmsr-547	27	5	with	with	ADP
aijmsr-547	27	6	the	the	DET
aijmsr-547	27	7	software	software	NOUN
aijmsr-547	27	8	package	package	NOUN
aijmsr-547	27	9	for	for	ADP
aijmsr-547	27	10	statistical	statistical	ADJ
aijmsr-547	27	11	analysis	analysis	NOUN
aijmsr-547	27	12	(	(	PUNCT
aijmsr-547	27	13	spss	spss	PROPN
aijmsr-547	27	14	®	®	PROPN
aijmsr-547	27	15	,	,	PUNCT
aijmsr-547	27	16	92	92	NUM
aijmsr-547	27	17	ibm	ibm	PROPN
aijmsr-547	27	18	2009	2009	NUM
aijmsr-547	27	19	,	,	PUNCT
aijmsr-547	27	20	version	version	NOUN
aijmsr-547	27	21	19	19	NUM
aijmsr-547	27	22	)	)	PUNCT
aijmsr-547	27	23	using	use	VERB
aijmsr-547	27	24	descriptive	descriptive	ADJ
aijmsr-547	27	25	statistics	statistic	NOUN
aijmsr-547	27	26	and	and	CCONJ
aijmsr-547	27	27	dispersion	dispersion	NOUN
aijmsr-547	27	28	analysis	analysis	NOUN
aijmsr-547	27	29	(	(	PUNCT
aijmsr-547	27	30	anova	anova	PROPN
aijmsr-547	27	31	)	)	PUNCT
aijmsr-547	27	32	.	.	PUNCT
aijmsr-547	28	1	we	we	PRON
aijmsr-547	28	2	considered	consider	VERB
aijmsr-547	28	3	the	the	DET
aijmsr-547	28	4	results	result	NOUN
aijmsr-547	28	5	for	for	ADP
aijmsr-547	28	6	significant	significant	ADJ
aijmsr-547	28	7	if	if	SCONJ
aijmsr-547	28	8	p<0.05	p<0.05	NOUN
aijmsr-547	28	9	.	.	PUNCT
aijmsr-547	29	1	3	3	X
aijmsr-547	29	2	.	.	NOUN
aijmsr-547	29	3	results	result	VERB
aijmsr-547	29	4	the	the	DET
aijmsr-547	29	5	analyzed	analyzed	ADJ
aijmsr-547	29	6	105	105	NUM
aijmsr-547	29	7	patients	patient	NOUN
aijmsr-547	29	8	in	in	ADP
aijmsr-547	29	9	our	our	PRON
aijmsr-547	29	10	study	study	NOUN
aijmsr-547	29	11	were	be	AUX
aijmsr-547	29	12	diagnosed	diagnose	VERB
aijmsr-547	29	13	with	with	ADP
aijmsr-547	29	14	proven	prove	VERB
aijmsr-547	29	15	urothelial	urothelial	ADJ
aijmsr-547	29	16	carcinoma	carcinoma	NOUN
aijmsr-547	29	17	.	.	PUNCT
aijmsr-547	30	1	still	still	ADV
aijmsr-547	30	2	,	,	PUNCT
aijmsr-547	30	3	we	we	PRON
aijmsr-547	30	4	must	must	AUX
aijmsr-547	30	5	clarify	clarify	VERB
aijmsr-547	30	6	that	that	SCONJ
aijmsr-547	30	7	we	we	PRON
aijmsr-547	30	8	included	include	VERB
aijmsr-547	30	9	a	a	DET
aijmsr-547	30	10	few	few	ADJ
aijmsr-547	30	11	cases	case	NOUN
aijmsr-547	30	12	of	of	ADP
aijmsr-547	30	13	urothelial	urothelial	ADJ
aijmsr-547	30	14	carcinoma	carcinoma	NOUN
aijmsr-547	30	15	of	of	ADP
aijmsr-547	30	16	renal	renal	ADJ
aijmsr-547	30	17	pelvis	pelvi	NOUN
aijmsr-547	30	18	and	and	CCONJ
aijmsr-547	30	19	ureter	ureter	NOUN
aijmsr-547	30	20	.	.	PUNCT
aijmsr-547	31	1	the	the	DET
aijmsr-547	31	2	patients	patient	NOUN
aijmsr-547	31	3	only	only	ADV
aijmsr-547	31	4	with	with	ADP
aijmsr-547	31	5	urothelial	urothelial	ADJ
aijmsr-547	31	6	carcinoma	carcinoma	NOUN
aijmsr-547	31	7	of	of	ADP
aijmsr-547	31	8	bladder	bladder	NOUN
aijmsr-547	31	9	were	be	AUX
aijmsr-547	31	10	95.2	95.2	NUM
aijmsr-547	31	11	%	%	NOUN
aijmsr-547	31	12	.	.	PUNCT
aijmsr-547	32	1	nevertheless	nevertheless	ADV
aijmsr-547	32	2	,	,	PUNCT
aijmsr-547	32	3	all	all	DET
aijmsr-547	32	4	analyzed	analyze	VERB
aijmsr-547	32	5	patients	patient	NOUN
aijmsr-547	32	6	were	be	AUX
aijmsr-547	32	7	characterized	characterize	VERB
aijmsr-547	32	8	and	and	CCONJ
aijmsr-547	32	9	separated	separate	VERB
aijmsr-547	32	10	by	by	ADP
aijmsr-547	32	11	two	two	NUM
aijmsr-547	32	12	features	feature	NOUN
aijmsr-547	32	13	:	:	PUNCT
aijmsr-547	32	14	1	1	X
aijmsr-547	32	15	)	)	PUNCT
aijmsr-547	32	16	by	by	ADP
aijmsr-547	32	17	localization	localization	NOUN
aijmsr-547	32	18	and	and	CCONJ
aijmsr-547	32	19	2	2	NUM
aijmsr-547	32	20	)	)	PUNCT
aijmsr-547	32	21	by	by	ADP
aijmsr-547	32	22	age	age	NOUN
aijmsr-547	32	23	and	and	CCONJ
aijmsr-547	32	24	gender	gender	NOUN
aijmsr-547	32	25	.	.	PUNCT
aijmsr-547	33	1	the	the	DET
aijmsr-547	33	2	most	most	ADV
aijmsr-547	33	3	common	common	ADJ
aijmsr-547	33	4	site	site	NOUN
aijmsr-547	33	5	of	of	ADP
aijmsr-547	33	6	urothelial	urothelial	ADJ
aijmsr-547	33	7	carcinoma	carcinoma	NOUN
aijmsr-547	33	8	was	be	AUX
aijmsr-547	33	9	in	in	ADP
aijmsr-547	33	10	the	the	DET
aijmsr-547	33	11	bladder	bladder	NOUN
aijmsr-547	33	12	,	,	PUNCT
aijmsr-547	33	13	presented	present	VERB
aijmsr-547	33	14	by	by	ADP
aijmsr-547	33	15	100	100	NUM
aijmsr-547	33	16	(	(	PUNCT
aijmsr-547	33	17	95.2	95.2	NUM
aijmsr-547	33	18	%	%	NOUN
aijmsr-547	33	19	)	)	PUNCT
aijmsr-547	33	20	cases	case	NOUN
aijmsr-547	33	21	.	.	PUNCT
aijmsr-547	34	1	second	second	ADJ
aijmsr-547	34	2	by	by	ADP
aijmsr-547	34	3	frequency	frequency	NOUN
aijmsr-547	34	4	urothelial	urothelial	ADJ
aijmsr-547	34	5	carcinoma	carcinoma	NOUN
aijmsr-547	34	6	was	be	AUX
aijmsr-547	34	7	in	in	ADP
aijmsr-547	34	8	the	the	DET
aijmsr-547	34	9	distal	distal	ADJ
aijmsr-547	34	10	part	part	NOUN
aijmsr-547	34	11	of	of	ADP
aijmsr-547	34	12	the	the	DET
aijmsr-547	34	13	ureter	ureter	NOUN
aijmsr-547	34	14	,	,	PUNCT
aijmsr-547	34	15	observed	observe	VERB
aijmsr-547	34	16	in	in	ADP
aijmsr-547	34	17	3(2.9	3(2.9	NUM
aijmsr-547	34	18	%	%	NOUN
aijmsr-547	34	19	)	)	PUNCT
aijmsr-547	34	20	cases	case	NOUN
aijmsr-547	34	21	.	.	PUNCT
aijmsr-547	35	1	the	the	DET
aijmsr-547	35	2	least	least	ADJ
aijmsr-547	35	3	of	of	ADP
aijmsr-547	35	4	the	the	DET
aijmsr-547	35	5	urothelial	urothelial	ADJ
aijmsr-547	35	6	carcinoma	carcinoma	NOUN
aijmsr-547	35	7	included	include	VERB
aijmsr-547	35	8	in	in	ADP
aijmsr-547	35	9	our	our	PRON
aijmsr-547	35	10	study	study	NOUN
aijmsr-547	35	11	were	be	AUX
aijmsr-547	35	12	3(1.9	3(1.9	NUM
aijmsr-547	35	13	%	%	NOUN
aijmsr-547	35	14	)	)	PUNCT
aijmsr-547	35	15	cases	case	NOUN
aijmsr-547	35	16	in	in	ADP
aijmsr-547	35	17	the	the	DET
aijmsr-547	35	18	renal	renal	ADJ
aijmsr-547	35	19	pelvis	pelvis	NOUN
aijmsr-547	35	20	.	.	PUNCT
aijmsr-547	36	1	these	these	DET
aijmsr-547	36	2	results	result	NOUN
aijmsr-547	36	3	are	be	AUX
aijmsr-547	36	4	presented	present	VERB
aijmsr-547	36	5	in	in	ADP
aijmsr-547	36	6	table	table	NOUN
aijmsr-547	36	7	1	1	NUM
aijmsr-547	36	8	.	.	PUNCT
aijmsr-547	36	9	table	table	NOUN
aijmsr-547	36	10	1	1	NUM
aijmsr-547	36	11	.	.	X
aijmsr-547	36	12	number	number	NOUN
aijmsr-547	36	13	and	and	CCONJ
aijmsr-547	36	14	percentage	percentage	NOUN
aijmsr-547	36	15	of	of	ADP
aijmsr-547	36	16	patients	patient	NOUN
aijmsr-547	36	17	with	with	ADP
aijmsr-547	36	18	urothelial	urothelial	ADJ
aijmsr-547	36	19	carcinoma	carcinoma	NOUN
aijmsr-547	36	20	according	accord	VERB
aijmsr-547	36	21	to	to	ADP
aijmsr-547	36	22	its	its	PRON
aijmsr-547	36	23	location	location	NOUN
aijmsr-547	36	24	bladder	bladder	NOUN
aijmsr-547	36	25	renal	renal	NOUN
aijmsr-547	36	26	pelvis	pelvi	VERB
aijmsr-547	36	27	ureter	ureter	ADP
aijmsr-547	36	28	total	total	ADJ
aijmsr-547	36	29	number	number	NOUN
aijmsr-547	36	30	of	of	ADP
aijmsr-547	36	31	patients	patient	NOUN
aijmsr-547	36	32	100	100	NUM
aijmsr-547	36	33	2	2	NUM
aijmsr-547	36	34	3	3	NUM
aijmsr-547	36	35	105	105	NUM
aijmsr-547	36	36	percentages	percentage	NOUN
aijmsr-547	36	37	of	of	ADP
aijmsr-547	36	38	patients	patient	NOUN
aijmsr-547	36	39	95.2	95.2	NUM
aijmsr-547	36	40	1.9	1.9	NUM
aijmsr-547	36	41	2.9	2.9	NUM
aijmsr-547	36	42	100	100	NUM
aijmsr-547	36	43	although	although	SCONJ
aijmsr-547	36	44	we	we	PRON
aijmsr-547	36	45	analyzed	analyze	VERB
aijmsr-547	36	46	our	our	PRON
aijmsr-547	36	47	result	result	NOUN
aijmsr-547	36	48	according	accord	VERB
aijmsr-547	36	49	to	to	ADP
aijmsr-547	36	50	the	the	DET
aijmsr-547	36	51	average	average	ADJ
aijmsr-547	36	52	age	age	NOUN
aijmsr-547	36	53	,	,	PUNCT
aijmsr-547	36	54	the	the	DET
aijmsr-547	36	55	mean	mean	ADJ
aijmsr-547	36	56	age	age	NOUN
aijmsr-547	36	57	of	of	ADP
aijmsr-547	36	58	our	our	PRON
aijmsr-547	36	59	patients	patient	NOUN
aijmsr-547	36	60	was	be	AUX
aijmsr-547	36	61	70±10.98	70±10.98	NUM
aijmsr-547	36	62	years	year	NOUN
aijmsr-547	36	63	,	,	PUNCT
aijmsr-547	36	64	as	as	SCONJ
aijmsr-547	36	65	the	the	DET
aijmsr-547	36	66	youngest	young	ADJ
aijmsr-547	36	67	patient	patient	NOUN
aijmsr-547	36	68	was	be	AUX
aijmsr-547	36	69	42	42	NUM
aijmsr-547	36	70	years	year	NOUN
aijmsr-547	36	71	old	old	ADJ
aijmsr-547	36	72	,	,	PUNCT
aijmsr-547	36	73	while	while	SCONJ
aijmsr-547	36	74	the	the	DET
aijmsr-547	36	75	oldest	old	ADJ
aijmsr-547	36	76	was	be	AUX
aijmsr-547	36	77	93	93	NUM
aijmsr-547	36	78	years	year	NOUN
aijmsr-547	36	79	old	old	ADJ
aijmsr-547	36	80	.	.	PUNCT
aijmsr-547	37	1	because	because	SCONJ
aijmsr-547	37	2	of	of	ADP
aijmsr-547	37	3	that	that	DET
aijmsr-547	37	4	heterogeneity	heterogeneity	NOUN
aijmsr-547	37	5	of	of	ADP
aijmsr-547	37	6	the	the	DET
aijmsr-547	37	7	age	age	NOUN
aijmsr-547	37	8	,	,	PUNCT
aijmsr-547	37	9	we	we	PRON
aijmsr-547	37	10	separated	separate	VERB
aijmsr-547	37	11	all	all	DET
aijmsr-547	37	12	patients	patient	NOUN
aijmsr-547	37	13	in	in	ADP
aijmsr-547	37	14	our	our	PRON
aijmsr-547	37	15	study	study	NOUN
aijmsr-547	37	16	into	into	ADP
aijmsr-547	37	17	six	six	NUM
aijmsr-547	37	18	decades	decade	NOUN
aijmsr-547	37	19	,	,	PUNCT
aijmsr-547	37	20	as	as	SCONJ
aijmsr-547	37	21	it	it	PRON
aijmsr-547	37	22	is	be	AUX
aijmsr-547	37	23	shown	show	VERB
aijmsr-547	37	24	in	in	ADP
aijmsr-547	37	25	figure	figure	NOUN
aijmsr-547	37	26	2	2	NUM
aijmsr-547	37	27	.	.	PUNCT
aijmsr-547	38	1	the	the	DET
aijmsr-547	38	2	majority	majority	NOUN
aijmsr-547	38	3	of	of	ADP
aijmsr-547	38	4	our	our	PRON
aijmsr-547	38	5	patients	patient	NOUN
aijmsr-547	38	6	fit	fit	VERB
aijmsr-547	38	7	in	in	ADP
aijmsr-547	38	8	the	the	DET
aijmsr-547	38	9	60	60	NUM
aijmsr-547	38	10	-	-	SYM
aijmsr-547	38	11	89	89	NUM
aijmsr-547	38	12	years	year	NOUN
aijmsr-547	38	13	of	of	ADP
aijmsr-547	38	14	age	age	NOUN
aijmsr-547	38	15	.	.	PUNCT
aijmsr-547	39	1	figure	figure	NOUN
aijmsr-547	39	2	2	2	NUM
aijmsr-547	39	3	.	.	PUNCT
aijmsr-547	40	1	the	the	DET
aijmsr-547	40	2	number	number	NOUN
aijmsr-547	40	3	and	and	CCONJ
aijmsr-547	40	4	%	%	NOUN
aijmsr-547	40	5	of	of	ADP
aijmsr-547	40	6	patients	patient	NOUN
aijmsr-547	40	7	with	with	ADP
aijmsr-547	40	8	urothelial	urothelial	ADJ
aijmsr-547	40	9	carcinoma	carcinoma	NOUN
aijmsr-547	40	10	according	accord	VERB
aijmsr-547	40	11	to	to	ADP
aijmsr-547	40	12	age	age	NOUN
aijmsr-547	40	13	divided	divide	VERB
aijmsr-547	40	14	into	into	ADP
aijmsr-547	40	15	decades	decade	NOUN
aijmsr-547	40	16	in	in	ADP
aijmsr-547	40	17	regards	regard	NOUN
aijmsr-547	40	18	to	to	ADP
aijmsr-547	40	19	the	the	DET
aijmsr-547	40	20	age	age	NOUN
aijmsr-547	40	21	and	and	CCONJ
aijmsr-547	40	22	nationality	nationality	NOUN
aijmsr-547	40	23	of	of	ADP
aijmsr-547	40	24	our	our	PRON
aijmsr-547	40	25	patients	patient	NOUN
aijmsr-547	40	26	with	with	ADP
aijmsr-547	40	27	urothelial	urothelial	ADJ
aijmsr-547	40	28	carcinoma	carcinoma	NOUN
aijmsr-547	40	29	of	of	ADP
aijmsr-547	40	30	the	the	DET
aijmsr-547	40	31	bladder	bladder	NOUN
aijmsr-547	40	32	,	,	PUNCT
aijmsr-547	40	33	we	we	PRON
aijmsr-547	40	34	did	do	AUX
aijmsr-547	40	35	not	not	PART
aijmsr-547	40	36	find	find	VERB
aijmsr-547	40	37	a	a	DET
aijmsr-547	40	38	significant	significant	ADJ
aijmsr-547	40	39	difference	difference	NOUN
aijmsr-547	40	40	between	between	ADP
aijmsr-547	40	41	them	they	PRON
aijmsr-547	40	42	.	.	PUNCT
aijmsr-547	41	1	the	the	DET
aijmsr-547	41	2	median	median	ADJ
aijmsr-547	41	3	age	age	NOUN
aijmsr-547	41	4	of	of	ADP
aijmsr-547	41	5	the	the	DET
aijmsr-547	41	6	patients	patient	NOUN
aijmsr-547	41	7	from	from	ADP
aijmsr-547	41	8	bulgaria	bulgaria	PROPN
aijmsr-547	41	9	was	be	AUX
aijmsr-547	41	10	70.14	70.14	NUM
aijmsr-547	41	11	±11.16	±11.16	PROPN
aijmsr-547	41	12	years	year	NOUN
aijmsr-547	41	13	,	,	PUNCT
aijmsr-547	41	14	and	and	CCONJ
aijmsr-547	41	15	from	from	ADP
aijmsr-547	41	16	france	france	PROPN
aijmsr-547	41	17	was	be	AUX
aijmsr-547	41	18	69.62	69.62	NUM
aijmsr-547	41	19	±10.09	±10.09	NOUN
aijmsr-547	41	20	years	year	NOUN
aijmsr-547	41	21	,	,	PUNCT
aijmsr-547	41	22	p=0.873	p=0.873	PUNCT
aijmsr-547	41	23	.	.	PUNCT
aijmsr-547	42	1	this	this	PRON
aijmsr-547	42	2	is	be	AUX
aijmsr-547	42	3	graphically	graphically	ADV
aijmsr-547	42	4	presented	present	VERB
aijmsr-547	42	5	in	in	ADP
aijmsr-547	42	6	figure	figure	NOUN
aijmsr-547	42	7	3	3	NUM
aijmsr-547	42	8	40	40	NUM
aijmsr-547	42	9	-	-	SYM
aijmsr-547	42	10	49	49	NUM
aijmsr-547	42	11	50	50	NUM
aijmsr-547	42	12	-	-	SYM
aijmsr-547	42	13	59	59	NUM
aijmsr-547	42	14	60	60	NUM
aijmsr-547	42	15	-	-	SYM
aijmsr-547	42	16	69	69	NUM
aijmsr-547	42	17	70	70	NUM
aijmsr-547	42	18	-	-	SYM
aijmsr-547	42	19	79	79	NUM
aijmsr-547	42	20	80	80	NUM
aijmsr-547	42	21	-	-	SYM
aijmsr-547	42	22	89	89	NUM
aijmsr-547	42	23	90	90	NUM
aijmsr-547	42	24	-	-	SYM
aijmsr-547	42	25	99	99	NUM
aijmsr-547	42	26	0	0	NUM
aijmsr-547	42	27	5	5	NUM
aijmsr-547	42	28	10	10	NUM
aijmsr-547	42	29	15	15	NUM
aijmsr-547	42	30	20	20	NUM
aijmsr-547	42	31	25	25	NUM
aijmsr-547	42	32	30	30	NUM
aijmsr-547	42	33	35	35	NUM
aijmsr-547	42	34	40	40	NUM
aijmsr-547	42	35	copyright	copyright	NOUN
aijmsr-547	42	36	©	©	PROPN
aijmsr-547	42	37	cc	cc	NOUN
aijmsr-547	42	38	-	-	PUNCT
aijmsr-547	42	39	by	by	ADP
aijmsr-547	42	40	-	-	PUNCT
aijmsr-547	42	41	nc	nc	PROPN
aijmsr-547	42	42	2020	2020	NUM
aijmsr-547	42	43	,	,	PUNCT
aijmsr-547	42	44	cribfb	cribfb	VERB
aijmsr-547	42	45	|	|	CCONJ
aijmsr-547	42	46	aijmsr	aijmsr	NOUN
aijmsr-547	42	47	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-547	42	48	american	american	PROPN
aijmsr-547	42	49	international	international	PROPN
aijmsr-547	42	50	journal	journal	PROPN
aijmsr-547	42	51	of	of	ADP
aijmsr-547	42	52	multidisciplinary	multidisciplinary	ADJ
aijmsr-547	42	53	scientific	scientific	ADJ
aijmsr-547	42	54	research	research	NOUN
aijmsr-547	42	55	vol	vol	NOUN
aijmsr-547	42	56	.	.	PROPN
aijmsr-547	43	1	6	6	NUM
aijmsr-547	43	2	,	,	PUNCT
aijmsr-547	43	3	no	no	INTJ
aijmsr-547	43	4	.	.	NOUN
aijmsr-547	43	5	1	1	NUM
aijmsr-547	43	6	;	;	PUNCT
aijmsr-547	43	7	2020	2020	NUM
aijmsr-547	43	8	3	3	NUM
aijmsr-547	43	9	figure	figure	NOUN
aijmsr-547	43	10	3	3	NUM
aijmsr-547	43	11	.	.	NOUN
aijmsr-547	43	12	differences	difference	NOUN
aijmsr-547	43	13	in	in	ADP
aijmsr-547	43	14	the	the	DET
aijmsr-547	43	15	average	average	ADJ
aijmsr-547	43	16	age	age	NOUN
aijmsr-547	43	17	of	of	ADP
aijmsr-547	43	18	patients	patient	NOUN
aijmsr-547	43	19	according	accord	VERB
aijmsr-547	43	20	to	to	ADP
aijmsr-547	43	21	the	the	DET
aijmsr-547	43	22	nationality	nationality	NOUN
aijmsr-547	43	23	we	we	PRON
aijmsr-547	43	24	have	have	AUX
aijmsr-547	43	25	obtained	obtain	VERB
aijmsr-547	43	26	the	the	DET
aijmsr-547	43	27	following	following	ADJ
aijmsr-547	43	28	results	result	NOUN
aijmsr-547	43	29	according	accord	VERB
aijmsr-547	43	30	to	to	ADP
aijmsr-547	43	31	the	the	DET
aijmsr-547	43	32	gender	gender	NOUN
aijmsr-547	43	33	of	of	ADP
aijmsr-547	43	34	the	the	DET
aijmsr-547	43	35	patients	patient	NOUN
aijmsr-547	43	36	form	form	VERB
aijmsr-547	43	37	cohort	cohort	NOUN
aijmsr-547	43	38	comprised	comprise	VERB
aijmsr-547	43	39	of	of	ADP
aijmsr-547	43	40	105	105	NUM
aijmsr-547	43	41	patients	patient	NOUN
aijmsr-547	43	42	with	with	ADP
aijmsr-547	43	43	urothelial	urothelial	ADJ
aijmsr-547	43	44	carcinoma	carcinoma	NOUN
aijmsr-547	43	45	:	:	PUNCT
aijmsr-547	43	46	72.4	72.4	NUM
aijmsr-547	43	47	%	%	NOUN
aijmsr-547	43	48	(	(	PUNCT
aijmsr-547	43	49	76/105	76/105	NUM
aijmsr-547	43	50	)	)	PUNCT
aijmsr-547	43	51	were	be	AUX
aijmsr-547	43	52	males	male	NOUN
aijmsr-547	43	53	,	,	PUNCT
aijmsr-547	43	54	and	and	CCONJ
aijmsr-547	43	55	27.6	27.6	NUM
aijmsr-547	43	56	%	%	NOUN
aijmsr-547	43	57	(	(	PUNCT
aijmsr-547	43	58	29/105	29/105	NUM
aijmsr-547	43	59	)	)	PUNCT
aijmsr-547	43	60	were	be	AUX
aijmsr-547	43	61	females	female	NOUN
aijmsr-547	43	62	.	.	PUNCT
aijmsr-547	44	1	the	the	DET
aijmsr-547	44	2	data	datum	NOUN
aijmsr-547	44	3	are	be	AUX
aijmsr-547	44	4	graphically	graphically	ADV
aijmsr-547	44	5	presented	present	VERB
aijmsr-547	44	6	in	in	ADP
aijmsr-547	44	7	figue	figue	NOUN
aijmsr-547	44	8	4	4	NUM
aijmsr-547	44	9	.	.	PUNCT
aijmsr-547	45	1	figure	figure	VERB
aijmsr-547	45	2	4	4	NUM
aijmsr-547	45	3	.	.	PUNCT
aijmsr-547	46	1	distribution	distribution	NOUN
aijmsr-547	46	2	of	of	ADP
aijmsr-547	46	3	patients	patient	NOUN
aijmsr-547	46	4	according	accord	VERB
aijmsr-547	46	5	to	to	ADP
aijmsr-547	46	6	the	the	DET
aijmsr-547	46	7	gender	gender	NOUN
aijmsr-547	46	8	72	72	NUM
aijmsr-547	46	9	%	%	NOUN
aijmsr-547	46	10	28	28	NUM
aijmsr-547	46	11	%	%	NOUN
aijmsr-547	46	12	men	man	NOUN
aijmsr-547	46	13	women	woman	NOUN
aijmsr-547	46	14	р=0.873	р=0.873	ADV
aijmsr-547	46	15	copyright	copyright	NOUN
aijmsr-547	46	16	©	©	PROPN
aijmsr-547	46	17	cc	cc	NOUN
aijmsr-547	46	18	-	-	PUNCT
aijmsr-547	46	19	by	by	ADP
aijmsr-547	46	20	-	-	PUNCT
aijmsr-547	46	21	nc	nc	PROPN
aijmsr-547	46	22	2020	2020	NUM
aijmsr-547	46	23	,	,	PUNCT
aijmsr-547	46	24	cribfb	cribfb	VERB
aijmsr-547	46	25	|	|	CCONJ
aijmsr-547	46	26	aijmsr	aijmsr	NOUN
aijmsr-547	46	27	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-547	46	28	american	american	PROPN
aijmsr-547	46	29	international	international	PROPN
aijmsr-547	46	30	journal	journal	PROPN
aijmsr-547	46	31	of	of	ADP
aijmsr-547	46	32	multidisciplinary	multidisciplinary	ADJ
aijmsr-547	46	33	scientific	scientific	ADJ
aijmsr-547	46	34	research	research	NOUN
aijmsr-547	46	35	vol	vol	NOUN
aijmsr-547	46	36	.	.	PROPN
aijmsr-547	47	1	6	6	NUM
aijmsr-547	47	2	,	,	PUNCT
aijmsr-547	47	3	no	no	INTJ
aijmsr-547	47	4	.	.	NOUN
aijmsr-547	47	5	1	1	NUM
aijmsr-547	47	6	;	;	PUNCT
aijmsr-547	47	7	2020	2020	NUM
aijmsr-547	47	8	4	4	NUM
aijmsr-547	47	9	figure	figure	NOUN
aijmsr-547	47	10	5	5	NUM
aijmsr-547	47	11	.	.	PUNCT
aijmsr-547	48	1	distribution	distribution	NOUN
aijmsr-547	48	2	of	of	ADP
aijmsr-547	48	3	the	the	DET
aijmsr-547	48	4	patients	patient	NOUN
aijmsr-547	48	5	according	accord	VERB
aijmsr-547	48	6	to	to	ADP
aijmsr-547	48	7	their	their	PRON
aijmsr-547	48	8	nationality	nationality	NOUN
aijmsr-547	48	9	figures	figure	NOUN
aijmsr-547	48	10	4	4	NUM
aijmsr-547	48	11	and	and	CCONJ
aijmsr-547	48	12	5	5	NUM
aijmsr-547	48	13	show	show	VERB
aijmsr-547	48	14	the	the	DET
aijmsr-547	48	15	distribution	distribution	NOUN
aijmsr-547	48	16	of	of	ADP
aijmsr-547	48	17	urothelial	urothelial	ADJ
aijmsr-547	48	18	carcinoma	carcinoma	NOUN
aijmsr-547	48	19	of	of	ADP
aijmsr-547	48	20	bladder	bladder	NOUN
aijmsr-547	48	21	by	by	ADP
aijmsr-547	48	22	gender	gender	NOUN
aijmsr-547	48	23	,	,	PUNCT
aijmsr-547	48	24	in	in	ADP
aijmsr-547	48	25	bulgarian	bulgarian	ADJ
aijmsr-547	48	26	and	and	CCONJ
aijmsr-547	48	27	french	french	ADJ
aijmsr-547	48	28	samples	sample	NOUN
aijmsr-547	48	29	of	of	ADP
aijmsr-547	48	30	patients	patient	NOUN
aijmsr-547	48	31	with	with	ADP
aijmsr-547	48	32	a	a	DET
aijmsr-547	48	33	significant	significant	ADJ
aijmsr-547	48	34	difference	difference	NOUN
aijmsr-547	48	35	between	between	ADP
aijmsr-547	48	36	male	male	NOUN
aijmsr-547	48	37	and	and	CCONJ
aijmsr-547	48	38	female	female	NOUN
aijmsr-547	48	39	,	,	PUNCT
aijmsr-547	48	40	for	for	ADP
aijmsr-547	48	41	both	both	DET
aijmsr-547	48	42	countries	country	NOUN
aijmsr-547	48	43	.	.	PUNCT
aijmsr-547	49	1	in	in	ADP
aijmsr-547	49	2	essence	essence	NOUN
aijmsr-547	49	3	,	,	PUNCT
aijmsr-547	49	4	65/92	65/92	NUM
aijmsr-547	49	5	(	(	PUNCT
aijmsr-547	49	6	70.7	70.7	NUM
aijmsr-547	49	7	%	%	NOUN
aijmsr-547	49	8	)	)	PUNCT
aijmsr-547	49	9	for	for	ADP
aijmsr-547	49	10	bulgarian	bulgarian	ADJ
aijmsr-547	49	11	patients	patient	NOUN
aijmsr-547	49	12	and	and	CCONJ
aijmsr-547	49	13	11/13	11/13	NUM
aijmsr-547	49	14	(	(	PUNCT
aijmsr-547	49	15	84.6	84.6	NUM
aijmsr-547	49	16	%	%	NOUN
aijmsr-547	49	17	)	)	PUNCT
aijmsr-547	49	18	for	for	ADP
aijmsr-547	49	19	france	france	PROPN
aijmsr-547	49	20	were	be	AUX
aijmsr-547	49	21	males	male	NOUN
aijmsr-547	49	22	,	,	PUNCT
aijmsr-547	49	23	and	and	CCONJ
aijmsr-547	49	24	27/92	27/92	NUM
aijmsr-547	49	25	(	(	PUNCT
aijmsr-547	49	26	29.3	29.3	NUM
aijmsr-547	49	27	%	%	NOUN
aijmsr-547	49	28	)	)	PUNCT
aijmsr-547	49	29	in	in	ADP
aijmsr-547	49	30	bulgaria	bulgaria	PROPN
aijmsr-547	49	31	and	and	CCONJ
aijmsr-547	49	32	2/13	2/13	NUM
aijmsr-547	49	33	(	(	PUNCT
aijmsr-547	49	34	15.4	15.4	NUM
aijmsr-547	49	35	%	%	NOUN
aijmsr-547	49	36	)	)	PUNCT
aijmsr-547	49	37	in	in	ADP
aijmsr-547	49	38	france	france	PROPN
aijmsr-547	49	39	were	be	AUX
aijmsr-547	49	40	females	female	NOUN
aijmsr-547	49	41	.	.	PUNCT
aijmsr-547	50	1	descriptive	descriptive	ADJ
aijmsr-547	50	2	statistical	statistical	ADJ
aijmsr-547	50	3	methods	method	NOUN
aijmsr-547	50	4	showed	show	VERB
aijmsr-547	50	5	no	no	DET
aijmsr-547	50	6	significant	significant	ADJ
aijmsr-547	50	7	differences	difference	NOUN
aijmsr-547	50	8	in	in	ADP
aijmsr-547	50	9	patient	patient	NOUN
aijmsr-547	50	10	’s	’s	PART
aijmsr-547	50	11	samples	sample	NOUN
aijmsr-547	50	12	for	for	ADP
aijmsr-547	50	13	both	both	DET
aijmsr-547	50	14	countries	country	NOUN
aijmsr-547	50	15	,	,	PUNCT
aijmsr-547	50	16	p=0.292	p=0.292	X
aijmsr-547	50	17	.	.	X
aijmsr-547	51	1	4	4	X
aijmsr-547	51	2	.	.	NOUN
aijmsr-547	51	3	discussion	discussion	NOUN
aijmsr-547	51	4	bladder	bladder	NOUN
aijmsr-547	51	5	carcinoma	carcinoma	NOUN
aijmsr-547	51	6	still	still	ADV
aijmsr-547	51	7	presents	present	VERB
aijmsr-547	51	8	a	a	DET
aijmsr-547	51	9	diagnostic	diagnostic	ADJ
aijmsr-547	51	10	challenge	challenge	NOUN
aijmsr-547	51	11	,	,	PUNCT
aijmsr-547	51	12	and	and	CCONJ
aijmsr-547	51	13	it	it	PRON
aijmsr-547	51	14	remains	remain	VERB
aijmsr-547	51	15	the	the	DET
aijmsr-547	51	16	7th	7th	ADJ
aijmsr-547	51	17	most	most	ADV
aijmsr-547	51	18	common	common	ADJ
aijmsr-547	51	19	malignant	malignant	ADJ
aijmsr-547	51	20	disease	disease	NOUN
aijmsr-547	51	21	and	and	CCONJ
aijmsr-547	51	22	the	the	DET
aijmsr-547	51	23	2nd	2nd	ADJ
aijmsr-547	51	24	most	most	ADV
aijmsr-547	51	25	common	common	ADJ
aijmsr-547	51	26	neoplasia	neoplasia	NOUN
aijmsr-547	51	27	of	of	ADP
aijmsr-547	51	28	the	the	DET
aijmsr-547	51	29	excretory	excretory	NOUN
aijmsr-547	51	30	system	system	NOUN
aijmsr-547	51	31	right	right	ADV
aijmsr-547	51	32	after	after	ADP
aijmsr-547	51	33	prostatic	prostatic	ADJ
aijmsr-547	51	34	carcinoma	carcinoma	NOUN
aijmsr-547	51	35	.	.	PUNCT
aijmsr-547	52	1	it	it	PRON
aijmsr-547	52	2	is	be	AUX
aijmsr-547	52	3	also	also	ADV
aijmsr-547	52	4	characterized	characterize	VERB
aijmsr-547	52	5	by	by	ADP
aijmsr-547	52	6	a	a	DET
aijmsr-547	52	7	high	high	ADJ
aijmsr-547	52	8	tendency	tendency	NOUN
aijmsr-547	52	9	for	for	ADP
aijmsr-547	52	10	recurrence	recurrence	NOUN
aijmsr-547	52	11	,	,	PUNCT
aijmsr-547	52	12	necessitating	necessitate	VERB
aijmsr-547	52	13	expensive	expensive	ADJ
aijmsr-547	52	14	life	life	NOUN
aijmsr-547	52	15	-	-	PUNCT
aijmsr-547	52	16	long	long	ADJ
aijmsr-547	52	17	clinical	clinical	ADJ
aijmsr-547	52	18	surveillance	surveillance	NOUN
aijmsr-547	52	19	with	with	ADP
aijmsr-547	52	20	repeated	repeat	VERB
aijmsr-547	52	21	surgical	surgical	ADJ
aijmsr-547	52	22	interventions	intervention	NOUN
aijmsr-547	52	23	.	.	PUNCT
aijmsr-547	53	1	even	even	ADV
aijmsr-547	53	2	in	in	ADP
aijmsr-547	53	3	highly	highly	ADV
aijmsr-547	53	4	developed	develop	VERB
aijmsr-547	53	5	countries	country	NOUN
aijmsr-547	53	6	where	where	SCONJ
aijmsr-547	53	7	standards	standard	NOUN
aijmsr-547	53	8	of	of	ADP
aijmsr-547	53	9	medical	medical	ADJ
aijmsr-547	53	10	care	care	NOUN
aijmsr-547	53	11	and	and	CCONJ
aijmsr-547	53	12	treatment	treatment	NOUN
aijmsr-547	53	13	are	be	AUX
aijmsr-547	53	14	high	high	ADJ
aijmsr-547	53	15	,	,	PUNCT
aijmsr-547	53	16	outcomes	outcome	NOUN
aijmsr-547	53	17	remain	remain	VERB
aijmsr-547	53	18	unchanged	unchanged	ADJ
aijmsr-547	53	19	from	from	ADP
aijmsr-547	53	20	20	20	NUM
aijmsr-547	53	21	years	year	NOUN
aijmsr-547	53	22	ago	ago	ADV
aijmsr-547	53	23	.	.	PUNCT
aijmsr-547	54	1	urothelial	urothelial	ADJ
aijmsr-547	54	2	carcinoma	carcinoma	NOUN
aijmsr-547	54	3	of	of	ADP
aijmsr-547	54	4	the	the	DET
aijmsr-547	54	5	bladder	bladder	NOUN
aijmsr-547	54	6	is	be	AUX
aijmsr-547	54	7	a	a	DET
aijmsr-547	54	8	significant	significant	ADJ
aijmsr-547	54	9	public	public	ADJ
aijmsr-547	54	10	health	health	NOUN
aijmsr-547	54	11	problem	problem	NOUN
aijmsr-547	54	12	in	in	ADP
aijmsr-547	54	13	south	south	PROPN
aijmsr-547	54	14	europe	europe	PROPN
aijmsr-547	54	15	(	(	PUNCT
aijmsr-547	54	16	especially	especially	ADV
aijmsr-547	54	17	in	in	ADP
aijmsr-547	54	18	greece	greece	PROPN
aijmsr-547	54	19	,	,	PUNCT
aijmsr-547	54	20	spain	spain	PROPN
aijmsr-547	54	21	,	,	PUNCT
aijmsr-547	54	22	and	and	CCONJ
aijmsr-547	54	23	italy	italy	PROPN
aijmsr-547	54	24	)	)	PUNCT
aijmsr-547	54	25	and	and	CCONJ
aijmsr-547	54	26	the	the	DET
aijmsr-547	54	27	most	most	ADV
aijmsr-547	54	28	common	common	ADJ
aijmsr-547	54	29	cause	cause	NOUN
aijmsr-547	54	30	for	for	ADP
aijmsr-547	54	31	the	the	DET
aijmsr-547	54	32	lethal	lethal	ADJ
aijmsr-547	54	33	outcome	outcome	NOUN
aijmsr-547	54	34	of	of	ADP
aijmsr-547	54	35	malignancies	malignancy	NOUN
aijmsr-547	54	36	in	in	ADP
aijmsr-547	54	37	males	male	NOUN
aijmsr-547	54	38	,	,	PUNCT
aijmsr-547	54	39	and	and	CCONJ
aijmsr-547	54	40	in	in	ADP
aijmsr-547	54	41	lebanon	lebanon	PROPN
aijmsr-547	54	42	in	in	ADP
aijmsr-547	54	43	females	female	NOUN
aijmsr-547	54	44	(	(	PUNCT
aijmsr-547	54	45	bray	bray	PROPN
aijmsr-547	54	46	et	et	PROPN
aijmsr-547	54	47	al	al	PROPN
aijmsr-547	54	48	.	.	PROPN
aijmsr-547	54	49	,	,	PUNCT
aijmsr-547	54	50	2018	2018	NUM
aijmsr-547	54	51	)	)	PUNCT
aijmsr-547	54	52	.	.	PUNCT
aijmsr-547	55	1	this	this	DET
aijmsr-547	55	2	study	study	NOUN
aijmsr-547	55	3	demonstrated	demonstrate	VERB
aijmsr-547	55	4	that	that	SCONJ
aijmsr-547	55	5	the	the	DET
aijmsr-547	55	6	urothelial	urothelial	ADJ
aijmsr-547	55	7	carcinoma	carcinoma	NOUN
aijmsr-547	55	8	of	of	ADP
aijmsr-547	55	9	the	the	DET
aijmsr-547	55	10	bladder	bladder	NOUN
aijmsr-547	55	11	is	be	AUX
aijmsr-547	55	12	a	a	DET
aijmsr-547	55	13	high	high	ADJ
aijmsr-547	55	14	-	-	PUNCT
aijmsr-547	55	15	risk	risk	NOUN
aijmsr-547	55	16	tumor	tumor	NOUN
aijmsr-547	55	17	.	.	PUNCT
aijmsr-547	56	1	moreover	moreover	ADV
aijmsr-547	56	2	,	,	PUNCT
aijmsr-547	56	3	among	among	ADP
aijmsr-547	56	4	men	man	NOUN
aijmsr-547	56	5	,	,	PUNCT
aijmsr-547	56	6	this	this	PRON
aijmsr-547	56	7	is	be	AUX
aijmsr-547	56	8	the	the	DET
aijmsr-547	56	9	most	most	ADV
aijmsr-547	56	10	commonly	commonly	ADV
aijmsr-547	56	11	diagnosed	diagnose	VERB
aijmsr-547	56	12	malignancy	malignancy	NOUN
aijmsr-547	56	13	in	in	ADP
aijmsr-547	56	14	bulgaria	bulgaria	PROPN
aijmsr-547	56	15	and	and	CCONJ
aijmsr-547	56	16	france	france	PROPN
aijmsr-547	56	17	,	,	PUNCT
aijmsr-547	56	18	which	which	PRON
aijmsr-547	56	19	is	be	AUX
aijmsr-547	56	20	in	in	ADP
aijmsr-547	56	21	correspondence	correspondence	NOUN
aijmsr-547	56	22	with	with	ADP
aijmsr-547	56	23	the	the	DET
aijmsr-547	56	24	data	datum	NOUN
aijmsr-547	56	25	from	from	ADP
aijmsr-547	56	26	other	other	ADJ
aijmsr-547	56	27	studies	study	NOUN
aijmsr-547	56	28	.	.	PUNCT
aijmsr-547	57	1	according	accord	VERB
aijmsr-547	57	2	to	to	ADP
aijmsr-547	57	3	literature	literature	NOUN
aijmsr-547	57	4	,	,	PUNCT
aijmsr-547	57	5	bulgaria	bulgaria	PROPN
aijmsr-547	57	6	is	be	AUX
aijmsr-547	57	7	the	the	DET
aijmsr-547	57	8	only	only	ADJ
aijmsr-547	57	9	country	country	NOUN
aijmsr-547	57	10	where	where	SCONJ
aijmsr-547	57	11	males	male	NOUN
aijmsr-547	57	12	had	have	VERB
aijmsr-547	57	13	a	a	DET
aijmsr-547	57	14	significant	significant	ADJ
aijmsr-547	57	15	increase	increase	NOUN
aijmsr-547	57	16	in	in	ADP
aijmsr-547	57	17	both	both	DET
aijmsr-547	57	18	incidence	incidence	NOUN
aijmsr-547	57	19	and	and	CCONJ
aijmsr-547	57	20	mortality	mortality	NOUN
aijmsr-547	57	21	(	(	PUNCT
aijmsr-547	57	22	wong	wong	PROPN
aijmsr-547	57	23	et	et	PROPN
aijmsr-547	57	24	al	al	PROPN
aijmsr-547	57	25	.	.	PROPN
aijmsr-547	57	26	,	,	PUNCT
aijmsr-547	57	27	2018	2018	NUM
aijmsr-547	57	28	)	)	PUNCT
aijmsr-547	57	29	.	.	PUNCT
aijmsr-547	58	1	in	in	ADP
aijmsr-547	58	2	our	our	PRON
aijmsr-547	58	3	study	study	NOUN
aijmsr-547	58	4	,	,	PUNCT
aijmsr-547	58	5	we	we	PRON
aijmsr-547	58	6	also	also	ADV
aijmsr-547	58	7	established	establish	VERB
aijmsr-547	58	8	the	the	DET
aijmsr-547	58	9	ratio	ratio	NOUN
aijmsr-547	58	10	between	between	ADP
aijmsr-547	58	11	man	man	NOUN
aijmsr-547	58	12	and	and	CCONJ
aijmsr-547	58	13	women	woman	NOUN
aijmsr-547	58	14	was	be	AUX
aijmsr-547	58	15	3.2:1	3.2:1	NUM
aijmsr-547	58	16	,	,	PUNCT
aijmsr-547	58	17	and	and	CCONJ
aijmsr-547	58	18	the	the	DET
aijmsr-547	58	19	average	average	ADJ
aijmsr-547	58	20	age	age	NOUN
aijmsr-547	58	21	of	of	ADP
aijmsr-547	58	22	the	the	DET
aijmsr-547	58	23	patients	patient	NOUN
aijmsr-547	58	24	with	with	ADP
aijmsr-547	58	25	urothelial	urothelial	ADJ
aijmsr-547	58	26	carcinoma	carcinoma	NOUN
aijmsr-547	58	27	of	of	ADP
aijmsr-547	58	28	the	the	DET
aijmsr-547	58	29	bladder	bladder	NOUN
aijmsr-547	58	30	is	be	AUX
aijmsr-547	58	31	70.14	70.14	NUM
aijmsr-547	58	32	years	year	NOUN
aijmsr-547	58	33	on	on	ADP
aijmsr-547	58	34	average	average	ADJ
aijmsr-547	58	35	,	,	PUNCT
aijmsr-547	58	36	which	which	PRON
aijmsr-547	58	37	is	be	AUX
aijmsr-547	58	38	similar	similar	ADJ
aijmsr-547	58	39	to	to	ADP
aijmsr-547	58	40	the	the	DET
aijmsr-547	58	41	results	result	NOUN
aijmsr-547	58	42	of	of	ADP
aijmsr-547	58	43	almost	almost	ADV
aijmsr-547	58	44	all	all	PRON
aijmsr-547	58	45	published	publish	VERB
aijmsr-547	58	46	studies	study	NOUN
aijmsr-547	58	47	(	(	PUNCT
aijmsr-547	58	48	horstmann	horstmann	PROPN
aijmsr-547	58	49	et	et	PROPN
aijmsr-547	58	50	al	al	PROPN
aijmsr-547	58	51	.	.	PROPN
aijmsr-547	58	52	,	,	PUNCT
aijmsr-547	58	53	2008	2008	NUM
aijmsr-547	58	54	;	;	PUNCT
aijmsr-547	58	55	gandomani	gandomani	PROPN
aijmsr-547	58	56	et	et	PROPN
aijmsr-547	58	57	al	al	PROPN
aijmsr-547	58	58	.	.	PROPN
aijmsr-547	58	59	,	,	PUNCT
aijmsr-547	58	60	2017	2017	NUM
aijmsr-547	58	61	)	)	PUNCT
aijmsr-547	58	62	.	.	PUNCT
aijmsr-547	59	1	5	5	X
aijmsr-547	59	2	.	.	X
aijmsr-547	59	3	conclusion	conclusion	NOUN
aijmsr-547	59	4	this	this	DET
aijmsr-547	59	5	study	study	NOUN
aijmsr-547	59	6	demonstrated	demonstrate	VERB
aijmsr-547	59	7	that	that	SCONJ
aijmsr-547	59	8	bladder	bladder	NOUN
aijmsr-547	59	9	carcinoma	carcinoma	NOUN
aijmsr-547	59	10	is	be	AUX
aijmsr-547	59	11	not	not	PART
aijmsr-547	59	12	a	a	DET
aijmsr-547	59	13	“	"	PUNCT
aijmsr-547	59	14	simple	simple	ADJ
aijmsr-547	59	15	”	"	PUNCT
aijmsr-547	59	16	pathology	pathology	NOUN
aijmsr-547	59	17	but	but	CCONJ
aijmsr-547	59	18	a	a	DET
aijmsr-547	59	19	common	common	ADJ
aijmsr-547	59	20	and	and	CCONJ
aijmsr-547	59	21	aggressive	aggressive	ADJ
aijmsr-547	59	22	malignant	malignant	ADJ
aijmsr-547	59	23	disease	disease	NOUN
aijmsr-547	59	24	.	.	PUNCT
aijmsr-547	60	1	it	it	PRON
aijmsr-547	60	2	remains	remain	VERB
aijmsr-547	60	3	a	a	DET
aijmsr-547	60	4	diagnostic	diagnostic	ADJ
aijmsr-547	60	5	challenge	challenge	NOUN
aijmsr-547	60	6	.	.	PUNCT
aijmsr-547	61	1	as	as	SCONJ
aijmsr-547	61	2	we	we	PRON
aijmsr-547	61	3	described	describe	VERB
aijmsr-547	61	4	in	in	ADP
aijmsr-547	61	5	the	the	DET
aijmsr-547	61	6	interdiction	interdiction	NOUN
aijmsr-547	61	7	,	,	PUNCT
aijmsr-547	61	8	many	many	ADJ
aijmsr-547	61	9	factors	factor	NOUN
aijmsr-547	61	10	affect	affect	VERB
aijmsr-547	61	11	its	its	PRON
aijmsr-547	61	12	epidemiology	epidemiology	NOUN
aijmsr-547	61	13	.	.	PUNCT
aijmsr-547	62	1	still	still	ADV
aijmsr-547	62	2	,	,	PUNCT
aijmsr-547	62	3	most	most	ADJ
aijmsr-547	62	4	of	of	ADP
aijmsr-547	62	5	them	they	PRON
aijmsr-547	62	6	might	might	AUX
aijmsr-547	62	7	be	be	AUX
aijmsr-547	62	8	controlled	control	VERB
aijmsr-547	62	9	with	with	ADP
aijmsr-547	62	10	all	all	DET
aijmsr-547	62	11	common	common	ADJ
aijmsr-547	62	12	forces	force	NOUN
aijmsr-547	62	13	for	for	ADP
aijmsr-547	62	14	one	one	NUM
aijmsr-547	62	15	purpose	purpose	NOUN
aijmsr-547	62	16	only	only	ADV
aijmsr-547	62	17	–	–	PUNCT
aijmsr-547	62	18	reduces	reduce	VERB
aijmsr-547	62	19	its	its	PRON
aijmsr-547	62	20	incidence	incidence	NOUN
aijmsr-547	62	21	and	and	CCONJ
aijmsr-547	62	22	mortality	mortality	NOUN
aijmsr-547	62	23	.	.	PUNCT
aijmsr-547	63	1	conflict	conflict	NOUN
aijmsr-547	63	2	of	of	ADP
aijmsr-547	63	3	interests	interest	NOUN
aijmsr-547	63	4	the	the	DET
aijmsr-547	63	5	authors	author	NOUN
aijmsr-547	63	6	state	state	VERB
aijmsr-547	63	7	no	no	DET
aijmsr-547	63	8	conflict	conflict	NOUN
aijmsr-547	63	9	of	of	ADP
aijmsr-547	63	10	interest	interest	NOUN
aijmsr-547	63	11	.	.	PUNCT
aijmsr-547	64	1	references	reference	NOUN
aijmsr-547	64	2	aydin	aydin	PROPN
aijmsr-547	64	3	,	,	PUNCT
aijmsr-547	64	4	a.	a.	NOUN
aijmsr-547	64	5	m.	m.	NOUN
aijmsr-547	64	6	,	,	PUNCT
aijmsr-547	64	7	woldu	woldu	NOUN
aijmsr-547	64	8	,	,	PUNCT
aijmsr-547	64	9	s.	s.	PROPN
aijmsr-547	64	10	l.	l.	PROPN
aijmsr-547	64	11	,	,	PUNCT
aijmsr-547	64	12	hutchinson	hutchinson	PROPN
aijmsr-547	64	13	,	,	PUNCT
aijmsr-547	64	14	r.	r.	PROPN
aijmsr-547	64	15	c.	c.	PROPN
aijmsr-547	64	16	,	,	PUNCT
aijmsr-547	64	17	boegemann	boegemann	PROPN
aijmsr-547	64	18	,	,	PUNCT
aijmsr-547	64	19	m.	m.	NOUN
aijmsr-547	64	20	,	,	PUNCT
aijmsr-547	64	21	bagrodia	bagrodia	PROPN
aijmsr-547	64	22	,	,	PUNCT
aijmsr-547	64	23	a.	a.	NOUN
aijmsr-547	64	24	,	,	PUNCT
aijmsr-547	64	25	lotan	lotan	ADJ
aijmsr-547	64	26	,	,	PUNCT
aijmsr-547	64	27	y.	y.	PROPN
aijmsr-547	64	28	,	,	PUNCT
aijmsr-547	64	29	...	...	PUNCT
aijmsr-547	64	30	&	&	CCONJ
aijmsr-547	64	31	krabbe	krabbe	PROPN
aijmsr-547	64	32	,	,	PUNCT
aijmsr-547	64	33	l.	l.	PROPN
aijmsr-547	64	34	m.	m.	PROPN
aijmsr-547	64	35	(	(	PUNCT
aijmsr-547	64	36	2017	2017	NUM
aijmsr-547	64	37	)	)	PUNCT
aijmsr-547	64	38	.	.	PUNCT
aijmsr-547	65	1	spotlight	spotlight	NOUN
aijmsr-547	65	2	on	on	ADP
aijmsr-547	65	3	atezolizumab	atezolizumab	NOUN
aijmsr-547	65	4	and	and	CCONJ
aijmsr-547	65	5	its	its	PRON
aijmsr-547	65	6	potential	potential	NOUN
aijmsr-547	65	7	in	in	ADP
aijmsr-547	65	8	the	the	DET
aijmsr-547	65	9	treatment	treatment	NOUN
aijmsr-547	65	10	of	of	ADP
aijmsr-547	65	11	advanced	advanced	ADJ
aijmsr-547	65	12	urothelial	urothelial	ADJ
aijmsr-547	65	13	bladder	bladder	NOUN
aijmsr-547	65	14	cancer	cancer	NOUN
aijmsr-547	65	15	.	.	PUNCT
aijmsr-547	66	1	oncotargets	oncotarget	NOUN
aijmsr-547	66	2	and	and	CCONJ
aijmsr-547	66	3	therapy	therapy	NOUN
aijmsr-547	66	4	,	,	PUNCT
aijmsr-547	66	5	10	10	NUM
aijmsr-547	66	6	,	,	PUNCT
aijmsr-547	66	7	1487	1487	NUM
aijmsr-547	66	8	.	.	PUNCT
aijmsr-547	67	1	beltran	beltran	PROPN
aijmsr-547	67	2	la	la	PROPN
aijmsr-547	67	3	.	.	PROPN
aijmsr-547	68	1	cheng	cheng	PROPN
aijmsr-547	68	2	i	i	PROPN
aijmsr-547	68	3	,	,	PUNCT
aijmsr-547	68	4	raspollini	raspollini	PROPN
aijmsr-547	68	5	mr	mr	PROPN
aijmsr-547	68	6	,	,	PUNCT
aijmsr-547	68	7	marques	marques	PROPN
aijmsr-547	68	8	rc	rc	PROPN
aijmsr-547	68	9	,	,	PUNCT
aijmsr-547	68	10	scarpelli	scarpelli	PROPN
aijmsr-547	68	11	m	m	PROPN
aijmsr-547	68	12	,	,	PUNCT
aijmsr-547	68	13	gasparrini	gasparrini	PROPN
aijmsr-547	68	14	s	s	PROPN
aijmsr-547	68	15	,	,	PUNCT
aijmsr-547	68	16	montironi	montironi	PROPN
aijmsr-547	68	17	r.	r.	PROPN
aijmsr-547	68	18	(	(	PUNCT
aijmsr-547	68	19	2017	2017	NUM
aijmsr-547	68	20	)	)	PUNCT
aijmsr-547	68	21	.	.	PUNCT
aijmsr-547	69	1	variants	variant	NOUN
aijmsr-547	69	2	of	of	ADP
aijmsr-547	69	3	bladder	bladder	NOUN
aijmsr-547	69	4	cancer	cancer	NOUN
aijmsr-547	69	5	:	:	PUNCT
aijmsr-547	69	6	the	the	DET
aijmsr-547	69	7	pathologist	pathologist	NOUN
aijmsr-547	69	8	's	's	PART
aijmsr-547	69	9	point	point	NOUN
aijmsr-547	69	10	of	of	ADP
aijmsr-547	69	11	view	view	NOUN
aijmsr-547	69	12	.	.	PUNCT
aijmsr-547	70	1	european	european	ADJ
aijmsr-547	70	2	urology	urology	NOUN
aijmsr-547	70	3	supplements	supplement	NOUN
aijmsr-547	70	4	,	,	PUNCT
aijmsr-547	70	5	16(12	16(12	NUM
aijmsr-547	70	6	)	)	PUNCT
aijmsr-547	70	7	,	,	PUNCT
aijmsr-547	70	8	210–222	210–222	NUM
aijmsr-547	70	9	.	.	PUNCT
aijmsr-547	71	1	bulgaria	bulgaria	PROPN
aijmsr-547	71	2	france	france	PROPN
aijmsr-547	71	3	0	0	NUM
aijmsr-547	71	4	%	%	NOUN
aijmsr-547	71	5	10	10	NUM
aijmsr-547	71	6	%	%	NOUN
aijmsr-547	71	7	20	20	NUM
aijmsr-547	71	8	%	%	NOUN
aijmsr-547	71	9	30	30	NUM
aijmsr-547	71	10	%	%	NOUN
aijmsr-547	71	11	40	40	NUM
aijmsr-547	71	12	%	%	NOUN
aijmsr-547	71	13	50	50	NUM
aijmsr-547	71	14	%	%	NOUN
aijmsr-547	71	15	60	60	NUM
aijmsr-547	71	16	%	%	NOUN
aijmsr-547	71	17	70	70	NUM
aijmsr-547	71	18	%	%	NOUN
aijmsr-547	71	19	80	80	NUM
aijmsr-547	71	20	%	%	NOUN
aijmsr-547	71	21	90	90	NUM
aijmsr-547	71	22	%	%	NOUN
aijmsr-547	71	23	100	100	NUM
aijmsr-547	71	24	%	%	NOUN
aijmsr-547	71	25	male	male	ADJ
aijmsr-547	71	26	female	female	ADJ
aijmsr-547	71	27	https://www.ncbi.nlm.nih.gov/pubmed/?term=horstmann%20m%5bauthor%5d&cauthor=true&cauthor_uid=19108811	https://www.ncbi.nlm.nih.gov/pubmed/?term=horstmann%20m%5bauthor%5d&cauthor=true&cauthor_uid=19108811	NOUN
aijmsr-547	71	28	copyright	copyright	NOUN
aijmsr-547	71	29	©	©	PROPN
aijmsr-547	71	30	cc	cc	PROPN
aijmsr-547	71	31	-	-	PUNCT
aijmsr-547	71	32	by	by	ADP
aijmsr-547	71	33	-	-	PUNCT
aijmsr-547	71	34	nc	nc	PROPN
aijmsr-547	71	35	2020	2020	NUM
aijmsr-547	71	36	,	,	PUNCT
aijmsr-547	71	37	cribfb	cribfb	VERB
aijmsr-547	71	38	|	|	CCONJ
aijmsr-547	71	39	aijmsr	aijmsr	NOUN
aijmsr-547	71	40	www.cribfb.com/journal/index.php/aijmsr	www.cribfb.com/journal/index.php/aijmsr	VERB
aijmsr-547	71	41	american	american	PROPN
aijmsr-547	71	42	international	international	PROPN
aijmsr-547	71	43	journal	journal	PROPN
aijmsr-547	71	44	of	of	ADP
aijmsr-547	71	45	multidisciplinary	multidisciplinary	ADJ
aijmsr-547	71	46	scientific	scientific	ADJ
aijmsr-547	71	47	research	research	NOUN
aijmsr-547	71	48	vol	vol	NOUN
aijmsr-547	71	49	.	.	PROPN
aijmsr-547	72	1	6	6	NUM
aijmsr-547	72	2	,	,	PUNCT
aijmsr-547	72	3	no	no	INTJ
aijmsr-547	72	4	.	.	NOUN
aijmsr-547	72	5	1	1	NUM
aijmsr-547	72	6	;	;	PUNCT
aijmsr-547	72	7	2020	2020	NUM
aijmsr-547	72	8	5	5	NUM
aijmsr-547	72	9	battista	battista	PROPN
aijmsr-547	72	10	di	di	PROPN
aijmsr-547	72	11	pierro	pierro	PROPN
aijmsr-547	72	12	,	,	PUNCT
aijmsr-547	72	13	g.	g.	PROPN
aijmsr-547	72	14	,	,	PUNCT
aijmsr-547	72	15	gulia	gulia	PROPN
aijmsr-547	72	16	,	,	PUNCT
aijmsr-547	72	17	c.	c.	PROPN
aijmsr-547	72	18	,	,	PUNCT
aijmsr-547	72	19	cristini	cristini	PROPN
aijmsr-547	72	20	,	,	PUNCT
aijmsr-547	72	21	c.	c.	PROPN
aijmsr-547	72	22	,	,	PUNCT
aijmsr-547	72	23	fraietta	fraietta	PROPN
aijmsr-547	72	24	,	,	PUNCT
aijmsr-547	72	25	g.	g.	PROPN
aijmsr-547	72	26	,	,	PUNCT
aijmsr-547	72	27	marini	marini	PROPN
aijmsr-547	72	28	,	,	PUNCT
aijmsr-547	72	29	l.	l.	PROPN
aijmsr-547	72	30	,	,	PUNCT
aijmsr-547	72	31	grande	grande	PROPN
aijmsr-547	72	32	,	,	PUNCT
aijmsr-547	72	33	p.	p.	PROPN
aijmsr-547	72	34	,	,	PUNCT
aijmsr-547	72	35	...	...	PUNCT
aijmsr-547	72	36	&	&	CCONJ
aijmsr-547	72	37	piergentili	piergentili	PROPN
aijmsr-547	72	38	,	,	PUNCT
aijmsr-547	72	39	r.	r.	PROPN
aijmsr-547	72	40	(	(	PUNCT
aijmsr-547	72	41	2012	2012	NUM
aijmsr-547	72	42	)	)	PUNCT
aijmsr-547	72	43	.	.	PUNCT
aijmsr-547	73	1	bladder	bladder	NOUN
aijmsr-547	73	2	cancer	cancer	NOUN
aijmsr-547	73	3	:	:	PUNCT
aijmsr-547	73	4	a	a	DET
aijmsr-547	73	5	simple	simple	ADJ
aijmsr-547	73	6	model	model	NOUN
aijmsr-547	73	7	becomes	become	VERB
aijmsr-547	73	8	complex	complex	ADJ
aijmsr-547	73	9	.	.	PUNCT
aijmsr-547	74	1	current	current	ADJ
aijmsr-547	74	2	genomics	genomic	NOUN
aijmsr-547	74	3	,	,	PUNCT
aijmsr-547	74	4	13(5	13(5	NUM
aijmsr-547	74	5	)	)	PUNCT
aijmsr-547	74	6	,	,	PUNCT
aijmsr-547	74	7	395	395	NUM
aijmsr-547	74	8	-	-	SYM
aijmsr-547	74	9	415	415	NUM
aijmsr-547	74	10	.	.	PUNCT
aijmsr-547	75	1	bray	bray	PROPN
aijmsr-547	75	2	,	,	PUNCT
aijmsr-547	75	3	f.	f.	PROPN
aijmsr-547	75	4	,	,	PUNCT
aijmsr-547	75	5	ferlay	ferlay	PROPN
aijmsr-547	75	6	,	,	PUNCT
aijmsr-547	75	7	j.	j.	PROPN
aijmsr-547	75	8	,	,	PUNCT
aijmsr-547	75	9	soerjomataram	soerjomataram	PROPN
aijmsr-547	75	10	,	,	PUNCT
aijmsr-547	75	11	i.	i.	PROPN
aijmsr-547	75	12	,	,	PUNCT
aijmsr-547	75	13	siegel	siegel	PROPN
aijmsr-547	75	14	,	,	PUNCT
aijmsr-547	75	15	r.	r.	PROPN
aijmsr-547	75	16	l.	l.	PROPN
aijmsr-547	75	17	,	,	PUNCT
aijmsr-547	75	18	torre	torre	PROPN
aijmsr-547	75	19	,	,	PUNCT
aijmsr-547	75	20	l.	l.	PROPN
aijmsr-547	75	21	a.	a.	PROPN
aijmsr-547	75	22	,	,	PUNCT
aijmsr-547	75	23	&	&	CCONJ
aijmsr-547	75	24	jemal	jemal	ADJ
aijmsr-547	75	25	,	,	PUNCT
aijmsr-547	75	26	a.	a.	NOUN
aijmsr-547	75	27	(	(	PUNCT
aijmsr-547	75	28	2018	2018	NUM
aijmsr-547	75	29	)	)	PUNCT
aijmsr-547	75	30	.	.	PUNCT
aijmsr-547	76	1	global	global	ADJ
aijmsr-547	76	2	cancer	cancer	NOUN
aijmsr-547	76	3	statistics	statistic	NOUN
aijmsr-547	76	4	2018	2018	NUM
aijmsr-547	76	5	:	:	PUNCT
aijmsr-547	76	6	globocan	globocan	PROPN
aijmsr-547	76	7	estimates	estimate	NOUN
aijmsr-547	76	8	of	of	ADP
aijmsr-547	76	9	incidence	incidence	NOUN
aijmsr-547	76	10	and	and	CCONJ
aijmsr-547	76	11	mortality	mortality	NOUN
aijmsr-547	76	12	worldwide	worldwide	ADV
aijmsr-547	76	13	for	for	ADP
aijmsr-547	76	14	36	36	NUM
aijmsr-547	76	15	cancers	cancer	NOUN
aijmsr-547	76	16	in	in	ADP
aijmsr-547	76	17	185	185	NUM
aijmsr-547	76	18	countries	country	NOUN
aijmsr-547	76	19	.	.	PUNCT
aijmsr-547	77	1	ca	can	AUX
aijmsr-547	77	2	:	:	PUNCT
aijmsr-547	77	3	a	a	DET
aijmsr-547	77	4	cancer	cancer	NOUN
aijmsr-547	77	5	journal	journal	NOUN
aijmsr-547	77	6	for	for	ADP
aijmsr-547	77	7	clinicians	clinician	NOUN
aijmsr-547	77	8	,	,	PUNCT
aijmsr-547	77	9	68(6	68(6	NOUN
aijmsr-547	77	10	)	)	PUNCT
aijmsr-547	77	11	,	,	PUNCT
aijmsr-547	77	12	394	394	NUM
aijmsr-547	77	13	-	-	SYM
aijmsr-547	77	14	424	424	NUM
aijmsr-547	77	15	.	.	PUNCT
aijmsr-547	78	1	carneiro	carneiro	PROPN
aijmsr-547	78	2	,	,	PUNCT
aijmsr-547	78	3	b.	b.	PROPN
aijmsr-547	78	4	a.	a.	PROPN
aijmsr-547	78	5	,	,	PUNCT
aijmsr-547	78	6	meeks	meeks	PROPN
aijmsr-547	78	7	,	,	PUNCT
aijmsr-547	78	8	j.	j.	PROPN
aijmsr-547	78	9	j.	j.	PROPN
aijmsr-547	78	10	,	,	PUNCT
aijmsr-547	78	11	kuzel	kuzel	PROPN
aijmsr-547	78	12	,	,	PUNCT
aijmsr-547	78	13	t.	t.	PROPN
aijmsr-547	78	14	m.	m.	NOUN
aijmsr-547	78	15	,	,	PUNCT
aijmsr-547	78	16	scaranti	scaranti	ADJ
aijmsr-547	78	17	,	,	PUNCT
aijmsr-547	78	18	m.	m.	NOUN
aijmsr-547	78	19	,	,	PUNCT
aijmsr-547	78	20	abdulkadir	abdulkadir	PROPN
aijmsr-547	78	21	,	,	PUNCT
aijmsr-547	78	22	s.	s.	PROPN
aijmsr-547	78	23	a.	a.	PROPN
aijmsr-547	78	24	,	,	PUNCT
aijmsr-547	78	25	&	&	CCONJ
aijmsr-547	78	26	giles	giles	PROPN
aijmsr-547	78	27	,	,	PUNCT
aijmsr-547	78	28	f.	f.	PROPN
aijmsr-547	78	29	j.	j.	PROPN
aijmsr-547	78	30	(	(	PUNCT
aijmsr-547	78	31	2015	2015	NUM
aijmsr-547	78	32	)	)	PUNCT
aijmsr-547	78	33	.	.	PUNCT
aijmsr-547	79	1	emerging	emerge	VERB
aijmsr-547	79	2	therapeutic	therapeutic	ADJ
aijmsr-547	79	3	targets	target	NOUN
aijmsr-547	79	4	in	in	ADP
aijmsr-547	79	5	bladder	bladder	NOUN
aijmsr-547	79	6	cancer	cancer	NOUN
aijmsr-547	79	7	.	.	PUNCT
aijmsr-547	80	1	cancer	cancer	NOUN
aijmsr-547	80	2	treatment	treatment	NOUN
aijmsr-547	80	3	reviews	review	NOUN
aijmsr-547	80	4	,	,	PUNCT
aijmsr-547	80	5	41(2	41(2	NUM
aijmsr-547	80	6	)	)	PUNCT
aijmsr-547	80	7	,	,	PUNCT
aijmsr-547	80	8	170	170	NUM
aijmsr-547	80	9	-	-	SYM
aijmsr-547	80	10	178	178	NUM
aijmsr-547	80	11	.	.	PUNCT
aijmsr-547	81	1	gandomani	gandomani	PROPN
aijmsr-547	81	2	,	,	PUNCT
aijmsr-547	81	3	h.	h.	PROPN
aijmsr-547	81	4	s.	s.	PROPN
aijmsr-547	81	5	,	,	PUNCT
aijmsr-547	81	6	tarazoj	tarazoj	PROPN
aijmsr-547	81	7	,	,	PUNCT
aijmsr-547	81	8	a.	a.	NOUN
aijmsr-547	81	9	a.	a.	PROPN
aijmsr-547	81	10	,	,	PUNCT
aijmsr-547	81	11	siri	siri	NOUN
aijmsr-547	81	12	,	,	PUNCT
aijmsr-547	81	13	f.	f.	PROPN
aijmsr-547	81	14	h.	h.	PROPN
aijmsr-547	81	15	,	,	PUNCT
aijmsr-547	81	16	karimi	karimi	PROPN
aijmsr-547	81	17	rozveh	rozveh	PROPN
aijmsr-547	81	18	,	,	PUNCT
aijmsr-547	81	19	a.	a.	PROPN
aijmsr-547	81	20	,	,	PUNCT
aijmsr-547	81	21	hosseini	hosseini	PROPN
aijmsr-547	81	22	,	,	PUNCT
aijmsr-547	81	23	s.	s.	PROPN
aijmsr-547	81	24	,	,	PUNCT
aijmsr-547	81	25	borujeni	borujeni	NOUN
aijmsr-547	81	26	,	,	PUNCT
aijmsr-547	81	27	n.	n.	PROPN
aijmsr-547	81	28	n.	n.	PROPN
aijmsr-547	81	29	,	,	PUNCT
aijmsr-547	81	30	...	...	PUNCT
aijmsr-547	81	31	&	&	CCONJ
aijmsr-547	81	32	salehiniya	salehiniya	PROPN
aijmsr-547	81	33	,	,	PUNCT
aijmsr-547	81	34	h.	h.	PROPN
aijmsr-547	81	35	(	(	PUNCT
aijmsr-547	81	36	2017	2017	NUM
aijmsr-547	81	37	)	)	PUNCT
aijmsr-547	81	38	.	.	PUNCT
aijmsr-547	82	1	essentials	essential	NOUN
aijmsr-547	82	2	of	of	ADP
aijmsr-547	82	3	bladder	bladder	NOUN
aijmsr-547	82	4	cancer	cancer	NOUN
aijmsr-547	82	5	worldwide	worldwide	ADV
aijmsr-547	82	6	:	:	PUNCT
aijmsr-547	82	7	incidence	incidence	NOUN
aijmsr-547	82	8	,	,	PUNCT
aijmsr-547	82	9	mortality	mortality	NOUN
aijmsr-547	82	10	rate	rate	NOUN
aijmsr-547	82	11	and	and	CCONJ
aijmsr-547	82	12	risk	risk	NOUN
aijmsr-547	82	13	factors	factor	NOUN
aijmsr-547	82	14	.	.	PUNCT
aijmsr-547	83	1	biomedical	biomedical	ADJ
aijmsr-547	83	2	research	research	NOUN
aijmsr-547	83	3	and	and	CCONJ
aijmsr-547	83	4	therapy	therapy	NOUN
aijmsr-547	83	5	,	,	PUNCT
aijmsr-547	83	6	4(9	4(9	NUM
aijmsr-547	83	7	)	)	PUNCT
aijmsr-547	83	8	,	,	PUNCT
aijmsr-547	83	9	1638	1638	NUM
aijmsr-547	83	10	-	-	SYM
aijmsr-547	83	11	55	55	NUM
aijmsr-547	83	12	.	.	PUNCT
aijmsr-547	84	1	gilbert	gilbert	PROPN
aijmsr-547	84	2	,	,	PUNCT
aijmsr-547	84	3	d.	d.	PROPN
aijmsr-547	84	4	g.	g.	PROPN
aijmsr-547	84	5	,	,	PUNCT
aijmsr-547	84	6	mcclernon	mcclernon	PROPN
aijmsr-547	84	7	,	,	PUNCT
aijmsr-547	84	8	f.	f.	PROPN
aijmsr-547	84	9	j.	j.	PROPN
aijmsr-547	84	10	,	,	PUNCT
aijmsr-547	84	11	rabinovich	rabinovich	NOUN
aijmsr-547	84	12	,	,	PUNCT
aijmsr-547	84	13	n.	n.	PROPN
aijmsr-547	84	14	e.	e.	PROPN
aijmsr-547	84	15	,	,	PUNCT
aijmsr-547	84	16	sugai	sugai	PROPN
aijmsr-547	84	17	,	,	PUNCT
aijmsr-547	84	18	c.	c.	NOUN
aijmsr-547	84	19	,	,	PUNCT
aijmsr-547	84	20	plath	plath	NOUN
aijmsr-547	84	21	,	,	PUNCT
aijmsr-547	84	22	l.	l.	PROPN
aijmsr-547	84	23	c.	c.	PROPN
aijmsr-547	84	24	,	,	PUNCT
aijmsr-547	84	25	asgaard	asgaard	NOUN
aijmsr-547	84	26	,	,	PUNCT
aijmsr-547	84	27	g.	g.	PROPN
aijmsr-547	84	28	,	,	PUNCT
aijmsr-547	84	29	...	...	PUNCT
aijmsr-547	84	30	&	&	CCONJ
aijmsr-547	84	31	botros	botros	PROPN
aijmsr-547	84	32	,	,	PUNCT
aijmsr-547	84	33	n.	n.	PROPN
aijmsr-547	84	34	(	(	PUNCT
aijmsr-547	84	35	2004	2004	NUM
aijmsr-547	84	36	)	)	PUNCT
aijmsr-547	84	37	.	.	PUNCT
aijmsr-547	85	1	effects	effect	NOUN
aijmsr-547	85	2	of	of	ADP
aijmsr-547	85	3	quitting	quit	VERB
aijmsr-547	85	4	smoking	smoke	VERB
aijmsr-547	85	5	on	on	ADP
aijmsr-547	85	6	eeg	eeg	NOUN
aijmsr-547	85	7	activation	activation	NOUN
aijmsr-547	85	8	and	and	CCONJ
aijmsr-547	85	9	attention	attention	NOUN
aijmsr-547	85	10	last	last	ADJ
aijmsr-547	85	11	for	for	ADP
aijmsr-547	85	12	more	more	ADJ
aijmsr-547	85	13	than	than	ADP
aijmsr-547	85	14	31	31	NUM
aijmsr-547	85	15	days	day	NOUN
aijmsr-547	85	16	and	and	CCONJ
aijmsr-547	85	17	are	be	AUX
aijmsr-547	85	18	more	more	ADV
aijmsr-547	85	19	severe	severe	ADJ
aijmsr-547	85	20	with	with	ADP
aijmsr-547	85	21	stress	stress	NOUN
aijmsr-547	85	22	,	,	PUNCT
aijmsr-547	85	23	dependence	dependence	NOUN
aijmsr-547	85	24	,	,	PUNCT
aijmsr-547	85	25	drd2	drd2	NOUN
aijmsr-547	85	26	a1	a1	NOUN
aijmsr-547	85	27	allele	allele	NOUN
aijmsr-547	85	28	,	,	PUNCT
aijmsr-547	85	29	and	and	CCONJ
aijmsr-547	85	30	depressive	depressive	ADJ
aijmsr-547	85	31	traits	trait	NOUN
aijmsr-547	85	32	.	.	PUNCT
aijmsr-547	86	1	nicotine	nicotine	PROPN
aijmsr-547	86	2	&	&	CCONJ
aijmsr-547	86	3	tobacco	tobacco	PROPN
aijmsr-547	86	4	research	research	NOUN
aijmsr-547	86	5	,	,	PUNCT
aijmsr-547	86	6	6(2	6(2	NUM
aijmsr-547	86	7	)	)	PUNCT
aijmsr-547	86	8	,	,	PUNCT
aijmsr-547	86	9	249	249	NUM
aijmsr-547	86	10	-	-	SYM
aijmsr-547	86	11	267	267	NUM
aijmsr-547	86	12	.	.	PUNCT
aijmsr-547	87	1	hartge	hartge	VERB
aijmsr-547	87	2	,	,	PUNCT
aijmsr-547	87	3	p.	p.	NOUN
aijmsr-547	87	4	,	,	PUNCT
aijmsr-547	87	5	harvey	harvey	PROPN
aijmsr-547	87	6	,	,	PUNCT
aijmsr-547	87	7	e.	e.	PROPN
aijmsr-547	87	8	b.	b.	PROPN
aijmsr-547	87	9	,	,	PUNCT
aijmsr-547	87	10	linehan	linehan	PROPN
aijmsr-547	87	11	,	,	PUNCT
aijmsr-547	87	12	w.	w.	PROPN
aijmsr-547	87	13	m.	m.	PROPN
aijmsr-547	87	14	,	,	PUNCT
aijmsr-547	87	15	silverman	silverman	PROPN
aijmsr-547	87	16	,	,	PUNCT
aijmsr-547	87	17	d.	d.	PROPN
aijmsr-547	87	18	t.	t.	PROPN
aijmsr-547	87	19	,	,	PUNCT
aijmsr-547	87	20	sullivan	sullivan	PROPN
aijmsr-547	87	21	,	,	PUNCT
aijmsr-547	87	22	j.	j.	PROPN
aijmsr-547	87	23	w.	w.	PROPN
aijmsr-547	87	24	,	,	PUNCT
aijmsr-547	87	25	hoover	hoover	PROPN
aijmsr-547	87	26	,	,	PUNCT
aijmsr-547	87	27	r.	r.	PROPN
aijmsr-547	87	28	n.	n.	PROPN
aijmsr-547	87	29	,	,	PUNCT
aijmsr-547	87	30	&	&	CCONJ
aijmsr-547	87	31	fraumeni	fraumeni	PROPN
aijmsr-547	87	32	,	,	PUNCT
aijmsr-547	87	33	j.	j.	PROPN
aijmsr-547	87	34	f.	f.	PROPN
aijmsr-547	87	35	(	(	PUNCT
aijmsr-547	87	36	1990	1990	NUM
aijmsr-547	87	37	)	)	PUNCT
aijmsr-547	87	38	.	.	PUNCT
aijmsr-547	88	1	unexplained	unexplained	ADJ
aijmsr-547	88	2	excess	excess	ADJ
aijmsr-547	88	3	risk	risk	NOUN
aijmsr-547	88	4	of	of	ADP
aijmsr-547	88	5	bladder	bladder	NOUN
aijmsr-547	88	6	cancer	cancer	NOUN
aijmsr-547	88	7	in	in	ADP
aijmsr-547	88	8	men	man	NOUN
aijmsr-547	88	9	.	.	PUNCT
aijmsr-547	89	1	jnci	jnci	PROPN
aijmsr-547	89	2	:	:	PUNCT
aijmsr-547	89	3	journal	journal	NOUN
aijmsr-547	89	4	of	of	ADP
aijmsr-547	89	5	the	the	DET
aijmsr-547	89	6	national	national	PROPN
aijmsr-547	89	7	cancer	cancer	PROPN
aijmsr-547	89	8	institute	institute	PROPN
aijmsr-547	89	9	,	,	PUNCT
aijmsr-547	89	10	82(20	82(20	NUM
aijmsr-547	89	11	)	)	PUNCT
aijmsr-547	89	12	,	,	PUNCT
aijmsr-547	89	13	16361640	16361640	NUM
aijmsr-547	89	14	.	.	PUNCT
aijmsr-547	90	1	horstmann	horstmann	PROPN
aijmsr-547	90	2	,	,	PUNCT
aijmsr-547	90	3	m.	m.	NOUN
aijmsr-547	90	4	,	,	PUNCT
aijmsr-547	90	5	witthuhn	witthuhn	PROPN
aijmsr-547	90	6	,	,	PUNCT
aijmsr-547	90	7	r.	r.	PROPN
aijmsr-547	90	8	,	,	PUNCT
aijmsr-547	90	9	falk	falk	NOUN
aijmsr-547	90	10	,	,	PUNCT
aijmsr-547	90	11	m.	m.	NOUN
aijmsr-547	90	12	,	,	PUNCT
aijmsr-547	90	13	&	&	CCONJ
aijmsr-547	90	14	stenzl	stenzl	PROPN
aijmsr-547	90	15	,	,	PUNCT
aijmsr-547	90	16	a.	a.	NOUN
aijmsr-547	90	17	(	(	PUNCT
aijmsr-547	90	18	2008	2008	NUM
aijmsr-547	90	19	)	)	PUNCT
aijmsr-547	90	20	.	.	PUNCT
aijmsr-547	91	1	gender	gender	NOUN
aijmsr-547	91	2	-	-	PUNCT
aijmsr-547	91	3	specific	specific	ADJ
aijmsr-547	91	4	differences	difference	NOUN
aijmsr-547	91	5	in	in	ADP
aijmsr-547	91	6	bladder	bladder	NOUN
aijmsr-547	91	7	cancer	cancer	NOUN
aijmsr-547	91	8	:	:	PUNCT
aijmsr-547	91	9	a	a	DET
aijmsr-547	91	10	retrospective	retrospective	ADJ
aijmsr-547	91	11	analysis	analysis	NOUN
aijmsr-547	91	12	.	.	PUNCT
aijmsr-547	92	1	gender	gender	NOUN
aijmsr-547	92	2	medicine	medicine	NOUN
aijmsr-547	92	3	,	,	PUNCT
aijmsr-547	92	4	5(4	5(4	NUM
aijmsr-547	92	5	)	)	PUNCT
aijmsr-547	92	6	,	,	PUNCT
aijmsr-547	92	7	385	385	NUM
aijmsr-547	92	8	-	-	SYM
aijmsr-547	92	9	394	394	NUM
aijmsr-547	92	10	.	.	PUNCT
aijmsr-547	93	1	moch	moch	PROPN
aijmsr-547	93	2	,	,	PUNCT
aijmsr-547	93	3	h.	h.	PROPN
aijmsr-547	93	4	,	,	PUNCT
aijmsr-547	93	5	cubilla	cubilla	PROPN
aijmsr-547	93	6	,	,	PUNCT
aijmsr-547	93	7	a.	a.	PROPN
aijmsr-547	93	8	l.	l.	PROPN
aijmsr-547	93	9	,	,	PUNCT
aijmsr-547	93	10	humphrey	humphrey	PROPN
aijmsr-547	93	11	,	,	PUNCT
aijmsr-547	93	12	p.	p.	PROPN
aijmsr-547	93	13	a.	a.	PROPN
aijmsr-547	93	14	,	,	PUNCT
aijmsr-547	93	15	reuter	reuter	PROPN
aijmsr-547	93	16	,	,	PUNCT
aijmsr-547	93	17	v.	v.	PROPN
aijmsr-547	93	18	e.	e.	PROPN
aijmsr-547	93	19	,	,	PUNCT
aijmsr-547	93	20	&	&	CCONJ
aijmsr-547	93	21	ulbright	ulbright	NOUN
aijmsr-547	93	22	,	,	PUNCT
aijmsr-547	93	23	t.	t.	NOUN
aijmsr-547	93	24	m.	m.	NOUN
aijmsr-547	93	25	(	(	PUNCT
aijmsr-547	93	26	2016	2016	NUM
aijmsr-547	93	27	)	)	PUNCT
aijmsr-547	93	28	.	.	PUNCT
aijmsr-547	94	1	the	the	DET
aijmsr-547	94	2	2016	2016	NUM
aijmsr-547	94	3	who	who	PRON
aijmsr-547	94	4	classification	classification	NOUN
aijmsr-547	94	5	of	of	ADP
aijmsr-547	94	6	tumours	tumour	NOUN
aijmsr-547	94	7	of	of	ADP
aijmsr-547	94	8	the	the	DET
aijmsr-547	94	9	urinary	urinary	ADJ
aijmsr-547	94	10	system	system	NOUN
aijmsr-547	94	11	and	and	CCONJ
aijmsr-547	94	12	male	male	ADJ
aijmsr-547	94	13	genital	genital	ADJ
aijmsr-547	94	14	organs	organ	NOUN
aijmsr-547	94	15	—	—	PUNCT
aijmsr-547	94	16	part	part	NOUN
aijmsr-547	94	17	a	a	PRON
aijmsr-547	94	18	:	:	PUNCT
aijmsr-547	94	19	renal	renal	ADJ
aijmsr-547	94	20	,	,	PUNCT
aijmsr-547	94	21	penile	penile	NOUN
aijmsr-547	94	22	,	,	PUNCT
aijmsr-547	94	23	and	and	CCONJ
aijmsr-547	94	24	testicular	testicular	ADJ
aijmsr-547	94	25	tumours	tumour	NOUN
aijmsr-547	94	26	.	.	PUNCT
aijmsr-547	95	1	european	european	ADJ
aijmsr-547	95	2	urology	urology	NOUN
aijmsr-547	95	3	,	,	PUNCT
aijmsr-547	95	4	70(1	70(1	NOUN
aijmsr-547	95	5	)	)	PUNCT
aijmsr-547	95	6	,	,	PUNCT
aijmsr-547	95	7	93	93	NUM
aijmsr-547	95	8	-	-	SYM
aijmsr-547	95	9	105	105	NUM
aijmsr-547	95	10	.	.	PUNCT
aijmsr-547	95	11	ploeg	ploeg	PROPN
aijmsr-547	95	12	,	,	PUNCT
aijmsr-547	95	13	m.	m.	NOUN
aijmsr-547	95	14	,	,	PUNCT
aijmsr-547	95	15	aben	aben	PROPN
aijmsr-547	95	16	,	,	PUNCT
aijmsr-547	95	17	k.	k.	PROPN
aijmsr-547	95	18	k.	k.	PROPN
aijmsr-547	95	19	,	,	PUNCT
aijmsr-547	95	20	&	&	CCONJ
aijmsr-547	95	21	kiemeney	kiemeney	PROPN
aijmsr-547	95	22	,	,	PUNCT
aijmsr-547	95	23	l.	l.	PROPN
aijmsr-547	95	24	a.	a.	PROPN
aijmsr-547	95	25	(	(	PUNCT
aijmsr-547	95	26	2009	2009	NUM
aijmsr-547	95	27	)	)	PUNCT
aijmsr-547	95	28	.	.	PUNCT
aijmsr-547	96	1	the	the	DET
aijmsr-547	96	2	present	present	ADJ
aijmsr-547	96	3	and	and	CCONJ
aijmsr-547	96	4	future	future	ADJ
aijmsr-547	96	5	burden	burden	NOUN
aijmsr-547	96	6	of	of	ADP
aijmsr-547	96	7	urinary	urinary	ADJ
aijmsr-547	96	8	bladder	bladder	NOUN
aijmsr-547	96	9	cancer	cancer	NOUN
aijmsr-547	96	10	in	in	ADP
aijmsr-547	96	11	the	the	DET
aijmsr-547	96	12	world	world	NOUN
aijmsr-547	96	13	.	.	PUNCT
aijmsr-547	97	1	world	world	PROPN
aijmsr-547	97	2	journal	journal	PROPN
aijmsr-547	97	3	of	of	ADP
aijmsr-547	97	4	urology	urology	NOUN
aijmsr-547	97	5	,	,	PUNCT
aijmsr-547	97	6	27(3	27(3	NUM
aijmsr-547	97	7	)	)	PUNCT
aijmsr-547	97	8	,	,	PUNCT
aijmsr-547	97	9	289	289	NUM
aijmsr-547	97	10	-	-	SYM
aijmsr-547	97	11	293	293	NUM
aijmsr-547	97	12	.	.	PUNCT
aijmsr-547	98	1	wong	wong	PROPN
aijmsr-547	98	2	,	,	PUNCT
aijmsr-547	98	3	m.	m.	PROPN
aijmsr-547	98	4	c.	c.	PROPN
aijmsr-547	98	5	,	,	PUNCT
aijmsr-547	98	6	fung	fung	PROPN
aijmsr-547	98	7	,	,	PUNCT
aijmsr-547	98	8	f.	f.	PROPN
aijmsr-547	98	9	d.	d.	PROPN
aijmsr-547	98	10	,	,	PUNCT
aijmsr-547	98	11	leung	leung	PROPN
aijmsr-547	98	12	,	,	PUNCT
aijmsr-547	98	13	c.	c.	PROPN
aijmsr-547	98	14	,	,	PUNCT
aijmsr-547	98	15	cheung	cheung	PROPN
aijmsr-547	98	16	,	,	PUNCT
aijmsr-547	98	17	w.	w.	PROPN
aijmsr-547	98	18	w.	w.	PROPN
aijmsr-547	98	19	,	,	PUNCT
aijmsr-547	98	20	goggins	goggins	PROPN
aijmsr-547	98	21	,	,	PUNCT
aijmsr-547	98	22	w.	w.	PROPN
aijmsr-547	98	23	b.	b.	PROPN
aijmsr-547	98	24	,	,	PUNCT
aijmsr-547	98	25	&	&	CCONJ
aijmsr-547	98	26	ng	ng	PROPN
aijmsr-547	98	27	,	,	PUNCT
aijmsr-547	98	28	c.	c.	PROPN
aijmsr-547	98	29	f.	f.	PROPN
aijmsr-547	98	30	(	(	PUNCT
aijmsr-547	98	31	2018	2018	NUM
aijmsr-547	98	32	)	)	PUNCT
aijmsr-547	98	33	.	.	PUNCT
aijmsr-547	99	1	the	the	DET
aijmsr-547	99	2	global	global	ADJ
aijmsr-547	99	3	epidemiology	epidemiology	NOUN
aijmsr-547	99	4	of	of	ADP
aijmsr-547	99	5	bladder	bladder	NOUN
aijmsr-547	99	6	cancer	cancer	NOUN
aijmsr-547	99	7	:	:	PUNCT
aijmsr-547	99	8	a	a	DET
aijmsr-547	99	9	joinpoint	joinpoint	NOUN
aijmsr-547	99	10	regression	regression	NOUN
aijmsr-547	99	11	analysis	analysis	NOUN
aijmsr-547	99	12	of	of	ADP
aijmsr-547	99	13	its	its	PRON
aijmsr-547	99	14	incidence	incidence	NOUN
aijmsr-547	99	15	and	and	CCONJ
aijmsr-547	99	16	mortality	mortality	NOUN
aijmsr-547	99	17	trends	trend	NOUN
aijmsr-547	99	18	and	and	CCONJ
aijmsr-547	99	19	projection	projection	NOUN
aijmsr-547	99	20	.	.	PUNCT
aijmsr-547	100	1	scientific	scientific	ADJ
aijmsr-547	100	2	reports	report	NOUN
aijmsr-547	100	3	,	,	PUNCT
aijmsr-547	100	4	8(1	8(1	NOUN
aijmsr-547	100	5	)	)	PUNCT
aijmsr-547	100	6	,	,	PUNCT
aijmsr-547	100	7	1	1	NUM
aijmsr-547	100	8	-	-	SYM
aijmsr-547	100	9	12	12	NUM
aijmsr-547	100	10	.	.	PUNCT
aijmsr-547	101	1	copyrights	copyright	NOUN
aijmsr-547	101	2	copyright	copyright	NOUN
aijmsr-547	101	3	for	for	ADP
aijmsr-547	101	4	this	this	DET
aijmsr-547	101	5	article	article	NOUN
aijmsr-547	101	6	is	be	AUX
aijmsr-547	101	7	retained	retain	VERB
aijmsr-547	101	8	by	by	ADP
aijmsr-547	101	9	the	the	DET
aijmsr-547	101	10	author(s	author(s	PROPN
aijmsr-547	101	11	)	)	PUNCT
aijmsr-547	101	12	,	,	PUNCT
aijmsr-547	101	13	with	with	ADP
aijmsr-547	101	14	first	first	ADJ
aijmsr-547	101	15	publication	publication	NOUN
aijmsr-547	101	16	rights	right	NOUN
aijmsr-547	101	17	granted	grant	VERB
aijmsr-547	101	18	to	to	ADP
aijmsr-547	101	19	the	the	DET
aijmsr-547	101	20	journal	journal	NOUN
aijmsr-547	101	21	.	.	PUNCT
aijmsr-547	102	1	this	this	PRON
aijmsr-547	102	2	is	be	AUX
aijmsr-547	102	3	an	an	DET
aijmsr-547	102	4	open	open	ADJ
aijmsr-547	102	5	-	-	PUNCT
aijmsr-547	102	6	access	access	NOUN
aijmsr-547	102	7	article	article	NOUN
aijmsr-547	102	8	distributed	distribute	VERB
aijmsr-547	102	9	under	under	ADP
aijmsr-547	102	10	the	the	DET
aijmsr-547	102	11	terms	term	NOUN
aijmsr-547	102	12	and	and	CCONJ
aijmsr-547	102	13	conditions	condition	NOUN
aijmsr-547	102	14	of	of	ADP
aijmsr-547	102	15	the	the	DET
aijmsr-547	102	16	creative	creative	ADJ
aijmsr-547	102	17	commons	common	NOUN
aijmsr-547	102	18	attribution	attribution	NOUN
aijmsr-547	102	19	license	license	NOUN
aijmsr-547	102	20	(	(	PUNCT
aijmsr-547	102	21	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
aijmsr-547	102	22	)	)	PUNCT
aijmsr-547	102	23	.	.	PUNCT